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Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a prevalence that has been 
increasing steadily and rapidly across the world, including the Caribbean region. It has negatively 
impacted individuals health and wellbeing, and in addition, it has increased the economic and social 
burden on the countries. T2DM management is an integral part of positive health outcomes, however, 
it has been poor in the Caribbean and is resulting in an alarming number of complications. The best 
way to reduce the negative outcomes associated with T2DM is to ensure that the disease is managed 
correctly. To do this, issues associated with poor T2DM management must be identified and 
disseminated to the public. 
 Aim 
This thesis aims to highlight and raise awareness of the disparities impacting T2DM management in 
the Caribbean region to assist with future research, developmental plans and strategies. From the main 
aim two study objectives were developed. The first objective was to compare the content and quality of 
the Caribbean and international clinical guidelines for managing T2DM. The second objective was to 
summarise the barriers and facilitators to T2DM management in the Caribbean region. 
Methods  
To address the aim of this research a formative research approach was used, this is to ensure that the 
Caribbean government, healthcare professionals and researchers are provided with some of the 
necessary data needed to plan and develop interventions. This formative research included two 
separate studies and methods, one to address each aim. The first study appraised T2DM management 
guidelines including the Caribbean guideline which compared the content and quality of guidelines 
using the AGREE II tool. The second study was a systematic review which summarised the barriers 
and facilitators to T2DM management in the Caribbean region. 
Results  
From the appraisal, the Caribbean clinical guideline was found to contain similar levels of T2DM 
management topics compared to six guidelines (one international and five country-specific guidelines) 
and contained higher content levels than the remaining three guidelines (two international and one 
country-specific). Three country-specific guidelines (Canada, England and Wales and Scotland) met 
the criteria of high-quality and could be recommended for current use in clinical practice. Four were 
only eligible for use in practice with modifications (two international and two country-specific). However, 
the country-specific guideline from the Caribbean as well as two additional guidelines (one international 
and one country-specific) were of low-quality and therefore, they were not recommended for use in 
practice. 
 III 
The systematic review included eight studies, all of which focused on the patients’ perspective. There 
were six synthesized findings which included barriers and facilitators of T2DM management. These 
include, From the participants perspective sociocultural norms, demands and pressures were found to 
impact self-management and general care of T2DM (moderate certainty evidence); From the 
participants perspective environmental context and resources were found to impact the management 
of T2DM (high certainty evidence); From a patients perspective support systems were influential on the 
general management of T2DM (high certainty evidence); From the participants perspective personal 
background and circumstances can encourage and limit good self-management and general 
management of T2DM (high certainty evidence); From the participants perspective emotional factors 
were found to influence patients’ actions towards management of T2DM (high certainty evidence); and 
from the participants perspective psychological factors were found to  influence  patients’ adherence to 
T2DM management (moderate certainty evidence). 
Summary 
With the aim of reducing the number of cases and deaths associated with T2DM, this research 
successfully addresses knowledge gaps by determining and presenting the quality of published clinical 
guidelines for T2DM management used by healthcare professionals. It also assesses the information 
being provided and summarizes the factors that hinder the promotion of good T2DM management in 
the Caribbean. The findings from these studies provide evidence that the Caribbean islands can use to 
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Chapter 1: Introduction 
1.1. Diabetes mellitus background  
The diabetes epidemic is accelerating rapidly and is known as one of the fastest-growing health 
challenges(1), especially in the Caribbean with its predilection to persons of black ethnicities(2). Diabetes 
mellitus (DM) is a chronic metabolic disease which was responsible for over 4.2 million deaths in 2019. 
DM is a disease where the pancreas cannot make insulin, or when the body is unable to use insulin to 
effectively regulate blood glucose.(3) There are mainly three common types of DM, type 1 diabetes 
mellitus (T1DM), type 2 diabetes mellitus (T2DM), and gestational diabetes mellitus (GDM). All of these 
result in hyperglycaemia but differ in pathophysiology, complications and treatments. The two most 
predominant types are T1DM and T2DM.(4–6)   
T1DM, which was once known as an insulin-dependent, juvenile or childhood-onset, occurs when the 
pancreas produces little or no insulin at all, resulting in high blood glucose levels in the body.(4) Although 
there is no known cause for T1DM, researchers assume that it is instigated by genetical and 
environmental factors. As one of the known terms “juvenile or childhood-onset” suggest, T1DM is 
commonly found in children and young adults, and cannot be prevented.(5,7) GDM occurs during 
pregnancy when a woman’s blood glucose levels are higher than normal, but below the diagnostic cut-
off/threshold for diabetes.(4,8) Women diagnosed with GDM are more likely to face complications during 
pregnancy and delivery. Also, both mother and children are at risk of developing T2DM in the future.(4,8) 
T2DM is a chronic metabolic condition where the body is unable to use insulin effectively, resulting in 
higher blood glucose levels. T2DM is the most common type of diabetes, affecting approximately 90% 
of people diagnosed with diabetes(9) and it is most prevalent among adults; however, the incidence 
among children has increased in recent years.(10,11) 
 
1.2. Type 2 diabetes mellitus background and diagnosis 
Diagnosis of T2DM is based on the presence of the following symptoms: increased thirst (polydipsia), 
increased appetite (polyphagia), increased urine frequency and volume (polyuria), increased 
occurrence of infections, fatigue, weight loss, abnormal healing, areas of darkened skin commonly 
found at the neck or armpits (acanthosis nigricans), tingling or numbness in the hands or feet 
(paraesthesia), and blurred vision.(12) When one or more of these symptoms are present, a diagnostic 
test is conducted via laboratory testing of blood plasma glucose concentrations. Screening is used to 
identify asymptomatic persons and high-risk individuals to ensure that their T2DM are managed and 
treated. This may include a screening test, which if positive, may indicate a possible diagnosis and 
hence diagnostic test should be conducted.(13)  
According to the National Institute for Diabetes and Digestive and Kidney Diseases and most guidelines 
(including the International Diabetes Federation (IDF)), the current standard diagnostic criteria for T2DM 
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includes glycated haemoglobin A1C (HbA1c) test, fasting plasma glucose, two-hour oral glucose 
tolerance test (OGTT), and random plasma glucose test (Table 1). The HbA1c test is now the most 
common and  most recommended test for diagnosing T2DM, it measures the average glucose levels 
in the blood for the past two to three months. Fasting plasma glucose (FPG) tests the blood glucose 
level at one point in time after 8-12 hours of fasting. The OGTT is done by using a glucose load 
containing the equivalent of 75g anhydrous glucose dissolved in water and testing an individual’s blood 
glucose after 8 hours fasting, and 2 hours after ingesting sugary drink. Lastly, random plasma glucose, 
it can be used at any time, but usually when an individual is experiencing severe diabetes symptoms 
such as hyperglycaemia.(13–16) The cut-off point for FPG in the diagnostic criteria for T2DM differs 
according to diabetes organisations; however, the cut-off points presented in Table 1 are used by WHO 
and many other diabetes organisations.  








Two-hour plasma glucose oral 
glucose tolerance test (OGTT) 
Random plasma 
glucose 
Normal  Below 5.7% Below 100 mg/dL (6.1 
mmol/L) 
Below 140 mg/dL (7.8 mmol/L) NA 
Pre-diabetes 5.7%–6.4% 100–125mg/dL (6.1-
7.0 mmol/L)  
140-199 mg/dL (7.8-11.0 mmol/L) NA 
Diabetes 6.5% and above 126 mg/dL and above 
(7.0 mmol/L) 
200 mg/dL and above  (11.1 mmol/L) 200 mg/dL and above 
(11.1 mmol/L) 
 
1.3. Risk factors for T2DM 
The risk of T2DM increases with the proportion of associated risk factors present.(2,17) Most common 
risk factors for T2DM are increasing age (especially adults between the age of 40-45), obesity, high 
waist circumference, coexisting hypertension and hyperlipidaemia (high or unhealthy levels of lipids 
(triglycerides and cholesterol), family history of T2DM, personal history of gestational diabetes as a 
mother and child, ethnicity (particularly South Asian, Chinese, African-Caribbean or Black African), 
unhealthy diet, persons with a sedentary lifestyle and physical inactivity and pre-diabetes.(2,18) Pre-
diabetes mellitus is also known as Impaired Glucose Tolerance (IGT) and Impaired Fasting Glycaemia 
(IFG). These conditions (IGT and IFG) are at the intermediate development phase of the disease. 
Hence, when individuals with blood sugar levels higher than the normal range of 140 - 199 mg/dL (7.8 
- 11 mmol/L) from the OGTT , but not high enough to be diagnosed as diabetes, they may be considered 
as having IGT or IFG and regarded being at increased risk of developing T2DM.(4,6,19) The three 




1.4. Global incidence and prevalence of T2DM  
Both the incidence and prevalence of DM, particularly T2DM, have increased over the years. Globally, 
the number of adults living with DM has tripled over the last 20 years and have surpassed the prediction 
of 438 million in 2025.(20) In 2019, it was estimated that 463 million adults were living with DM,  implying 
approximately 1 in 11 adults had DM; and, this figure is expected to increase by 237 million in 2045.(1,21) 
Table 2 shows the world’s age-adjusted prevalence of DM for those ages 20 to 79 years, which in 2019 
was 8.3%.(22) Of the seven IDF regions, Africa has the lowest age-adjusted prevalence, and this may 
be as a result of under-nutrition and lower levels of overweight, obesity and urbanisation.(22) Europe 
also has a low prevalence, falling below the world average; and this may be the result of effective control 
tools for blood glucose, blood pressure, lipids and associated complications.(23) All the other regions 
were above the World percentage. 
Table 2: Prevalence of diabetes in adults (20-79 years) in IDF Regions, by age-adjusted 
comparative diabetes prevalence 














2019 8.3% 4.7% 6.3% 12.2% 11.1% 8.5% 11.3% 11.4% 
2030  9.2% 5.1% 7.3% 13.3% 12.3% 9.5% 12.2% 12.4% 
2045 9.6% 5.2% 7.8% 13.9% 13.0% 9.9% 12.6% 12.8% 
IDF, 2019.(22) 
A major concern in 2019 was that China, India and the United States of America (USA) were the three 
countries which had the largest number of adults with diabetes (116.4, 77.0 and 31.0 million 
respectively). However, it is predicted that in 2045 Pakistan will take the place of and the USA with 
(37.1 million), this may be due to Pakistan being a developing country and majority of DM patients are 
under the age of 64.(22,24) Not only is the increasing numbers of people with diabetes alarming but it is 
also the fact that the prevalence of DM in low- and middle-income countries (LMICs) is also rapidly 
rising.(25) According to the IDF, in 2019, 79% of people with DM were living in LMICs.(26)  
 
1.5. Global Impact of T2DM 
1.5.1. Health impact of T2DM 
The burden of T2DM is considerable, and affects not only the patients but also their families/carers as 
well as the country’s economy and healthcare system.(27) T2DM increases the risk of health 
complications, which are usually outcomes of poor management(20), and this can be associated with 
long-term macro- and micro-vascular complications.(28) Macro-vascular complications are due to 
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damage to large blood vessels (arteries and veins); which includes coronary heart disease (CHD), 
peripheral arterial disease (PAD) and stroke. Micro-vascular complications are due to damage to the 
small blood vessels (capillaries), which includes diabetic retinopathy (blindness), diabetic nephropathy 
(kidney failure), and diabetic neuropathy (foot ulcers, infection and limb amputation). Other additional 
complications associated with T2DM are diabetic ketoacidosis (high production or build-up of ketones 
in the body), skin conditions, hearing impairment, oral complications (periodontist), sleep apnea, 
cancer, sexual problems in men (erectile dysfunction) and women (thrush or urinary tract infection), 
depression, pregnancy-related conditions (hyperglycaemia, preterm birth, birth defects, and organ 
dysfunctions) and death.(29)  
Generally, T2DM is associated with reduced quality of life and reduced life expectancy.(30) The disease 
can reduce life expectancy by five to seven years when 55 years old.(10,31,32) The global mortality from 
T2DM in 2019 was approximately 3.8 million deaths.(26,33) The IDF regions with the highest estimated 
number of DM-related adult deaths are Western Pacific and South-East Asia regions (1.3 and 1.2 million 
deaths respectively). While the region with the lowest number of DM-related adult deaths was South 
and Central America with 0.2 million.(22) Between 2000-2016, premature mortality due to DM steadily 
increased in LMICs, and as of 2019, 90% of all DM-related premature deaths and 87% of all DM-related 
deaths were in LMICs.(20) This could be the result of the difficulties faced in accessing care and the very 
low rate of DM diagnosis and control.(20) 
1.5.2. Economic and Social impact  
Direct cost   
DM has caused a financial strain all over the world, especially in LMICs. This financial strain includes 
the direct and indirect cost of DM. The annual direct cost of the disease globally is approximately 760 
billion US dollars, which equates to 10% of global health expenditure in 2019, this is expected to rise to 
845 billion by the year 2045.(17,27,34) As there are a large number of complications associated with DM, 
50% of the direct cost is required to treat these complications.(34) The direct cost includes medications, 
examinations, consultations, hospitalisations, emergency visits and treatment of complications.(35)  
In 2019, amongst the IDF regions, North America and the Caribbean region spent the most towards 
diabetes-related healthcare ($325 billion USD).(34) While among the WHO regions, in 2015, the cost of 
diabetes-related healthcare in Latin America and the Caribbean was between $102 and $123 billion 
USD.(36) However, due to the differences in public access to healthcare and wealth amongst the different 
countries, it is clear that expenditure is not proportionately allocated, or in other words, the Caribbean 
region makes up a small portion of the total estimated cost of the IDF and WHO regions.(37)  
Evidence has also shown that total diabetes-related health expenditure and mean diabetes-related 
health expenditure per person is higher in high-income countries than in LMICs (high-income countries 
$494 billion USD and $5339 USD, middle-income countries $264 billion USD and $753 USD and low-
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income countries spend $1 billion USD and $138 respectively).(34) It should also be known that in LMICs, 
patients are more likely to cover the cost of their treatment through out-of-pocket payments.(38,39) 
Indirect cost 
The second type of financial strain is indirect cost. In 2017, the majority of people with T2DM were 
between the ages of 40 and 59, which represented a significant proportion of the working population, 
thus having a negative impact on the economy.(17,27) Labour-force dropouts, absenteeism, mortality 
(premature death), reduced productivity when at work and inability to work due to disability are the main 
sources of indirect cost.(34) The indirect costs of T2DM add an additional 35% to the annual global 
expenditure.  
Intangible cost 
Intangible cost is a cost that cannot be quantified but can be identified, and this includes the social 
impact of T2DM. According to IDF, both the psychological and physical effect of T2DM on people living 
with the disease contributes to the intangible cost. This includes pain, discomfort, worry, fears and 
concerns of future complications and managing the disease, anxiety and depression.(34) There are some 
social factors which are known to affect the mental health of T2DM patients.(40,41) T2DM individuals are 
negatively impacted by social factors such as, employment complications, decreased productivity and 
education attainment potential health outcomes and increased healthcare cost. All these factors, both 
psychological and physical, can essentially lead to poor management in the future and affect the overall 
quality of life. 
1.6. Prevention of T2DM 
A healthy lifestyle can reduce the risk of developing T2DM especially if diagnosed with pre-diabetes.(11) 
Approximately 80% of T2DM cases can be prevented or delayed by change in lifestyle behaviours 
(increased physical activity and healthy diet). Lifestyle interventions are known to have a positive impact 
on behavioural outcomes and are known to be successful in reducing the incidence of T2DM, especially 
in patients who are at high risk.(42,43) A 6-year diet and exercise intervention showed a 42% reduction in 
the risk of developing T2DM.(11)  
IDF recommends increased physical activity should include 150 minutes per week at intervals (three to 
five days a week, 30-45 minutes), this is the same level of activity that is recommended for persons 
without DM. Individuals who are overweight may require more intensive physical activity to ensure 5%- 
7% weight loss and avoid regaining weight.(44) A healthy diet is also strongly advised and should consist 
mainly of high-fibre and low-glycaemic index foods, while sweets, sweetened drinks (including alcohol) 
and sugar are to be avoided. It is recommended that obese and overweight persons should reduce 
daily caloric intake by 500-600 calories and if possible, should follow a low-caloric diet  of about 800-
1200 calories per day with the help of a general practitioner or dietician.(44) In addition, WHO also 
recommends avoiding the use of tobacco, as smoking increases the risk of diabetes.(25) If a healthy 
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lifestyle change is not enough or is not successful, medications such as metformin and acarbose may 
be considered (such medications are discussed in detail in the following section).(44)  
 
1.7. Management of T2DM 
T2DM patients can live longer and healthier lives if T2DM is detected early and well managed.(45) The 
overall aim of T2DM management is to minimise the risk of long-term complications. This includes 
focuses on control of blood glucose and lipids, blood pressure, weight management, lifestyle factors, 
regular screening and inspection of eyes, kidneys, feet, oral health, cardiovascular health (to detect any 
damage and facilitate early treatment if required), medications(drug treatment), and assessing other 
factors such as mental health and fasting.(10,46–49) 
The steps taken to ensure the aims are met include incorporating healthy lifestyle interventions, oral 
medications and injectable insulin into T2DM patients regime. Both lifestyle changes and 
pharmacological treatment are necessary to effectively manage T2DM, however, lifestyle changes are 
usually the initial focus of T2DM management.(50) The same healthy lifestyle interventions used to 
prevent T2DM are the interventions used to manage it (healthy diet, regular physical activity, not 
smoking and maintaining healthy body weight).(11,26,44,51)  
When lifestyle measures alone do not control blood glucose levels or reduce the development or 
progression of T2DM complications, it can then be treated with antidiabetic drugs such as metformin, 
dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) mimetics, pioglitazone, 
sulfonylureas (SU), sodium-glucose cotransporter 2 inhibitors (SGLT-2) and insulin.(47)  According to the 
National Institute for Health and Care Excellence (NICE) antidiabetic drugs in general, are medicines 
used to control blood glucose levels amongst T2DM patients and are often used to intensify lifestyle 
interventions if HbA1c levels continue to rise.(10,47) Metformin lowers the blood glucose level by reducing 
the amount of sugar the liver releases into the blood, and it makes the body respond better to insulin; 
and, it is the first-line treatment for T2DM patients.(52) If HbA1c levels continue to rise metformin can be 
intensified by combining it with DPP-4, GLP-1, pioglitazone, SU or SGLT-2. When patients are unable 
to tolerate metformin, the other drugs would be combined and considered the second-line treatment. 
DPP-4 inhibitors stop the DPP-4 enzyme that destroys the hormone incretin, which is responsible for 
helping the body produce insulin when needed and reducing glucose production by the liver when it is 
not needed.(53) GLP-1 stimulates the release of insulin and subdues glucagon release, which causes a 
reduction in hepatic gluconeogenesis.(54) Hepatic gluconeogenesis is a pathway used by the body to 
produce glucose, at an increased rate it causes hypoglycaemia, a reduction is important to prevent this. 
Pioglitazone makes cells become more sensitive to insulin in the body. Sulfonylureas, on the other 
hand, raises the concentration of plasma insulin, which decreases blood glucose levels.(55) Lastly, 
SGLT-2 inhibitors inhibit SGLT-2 proteins in the renal tubules of the kidneys which are accountable for 
reabsorbing glucose back into the blood.  
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Insulin is used as an intensification drug (on patients who can or cannot take metformin) after all drug 
combinations have been exhausted and HbA1c. Insulin is used to increase the uptake of glucose by 
adipose tissue and muscle and suppress hepatic glucose release, this must however be injected as it 
is inactivated by gastrointestinal enzymes.(56) There are five main types of insulin: rapid-acting, short-
acting, intermediate-acting, long-acting, and pre-mixed. The most common types of insulin used in 
T2DM management are NPH insulin (intermediate-acting), insulin detemir (long-acting), insulin glargine 
(long-acting), pre-mixed or biphasic (combining intermediate-acting and short-acting insulin).(47) 
Appendix I shows the NICE algorithm for blood glucose-lowering therapy in adults with T2DM. 
Although the information may not represent what is used by other countries or organisations, it is very 
detailed and easy to follow.(47) 
Nearly all measures to assist withT2DM management are provided during a T2DM annual check-up or 
doctors visit, upon recommendation or request.(46) T2DM check-ups monitor the patients’ overall T2DM 
control and are vital in T2DM management, and requires health practitioners to provide care to patients 
by following recommended practice guidelines.(57) When healthcare professionals provide 
recommended care for T2DM patients, it increases the chances of patients living longer and 
healthier.(58) Participation of both patients and healthcare practitioners is, therefore, required for 
successful management of T2DM.(59) 
 
1.8. Burden of T2DM in the Caribbean region 
The Caribbean region is made up of multiple islands and has a total population of 43.58 million. All the 
islands share a similar culture even though they consist of different ethnic groups, languages and social 
norms. Although some islands are built and managed differently, they have all been significantly 
impacted by the T2DM epidemic. Most small countries in the region have limited data on T2DM, which 
has led to estimates provided to be based on extrapolations from studies done in other countries like 
Jamaica, Trinidad and Tobago, and Barbados.(37) In addition, most epidemiological data for the 
Caribbean were found merged with other countries to form regions, for example, North America and 
Caribbean region and Latin America and Caribbean region. 
Of the IDF regions, the prevalence of DM in adults (20-79 years) in the North America and Caribbean 
region was 11.1% in 2019 and is expected to increase by 1.9% by the year 2045. In 2013, the top 10 
countries for age-adjusted adult diabetes prevalence estimates in the North America and the Caribbean 
region consisted of only Caribbean countries.(37) Among the population living with DM in the Caribbean 
region, 95% of them have T2DM(60), this is higher than the global (90%) population living with DM. The 
5% difference may be due to many reasons including the increase in obesity prevalence and 
sedentarism in the Caribbean societies. The most recent data provided in 2010 highlighted that the 
prevalence of DM in the Caribbean region is approximately 9%, and this accounts for about 14% of all 
adult deaths in the Caribbean.(61)  
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In many Caribbean islands, DM has been one of the top two causes of mortality.(62) T2DM is also 
associated with substantial morbidity in the North America and Caribbean region. However, as data is 
more limited on the Caribbean few studies have been published on the high number of complications 
associated with T2DM. In the Bahamas, Barbados, Jamaica and Trinidad diabetes accounted for 
roughly 28% end-stage renal disease cases.(37) A study conducted among T2DM patients in Trinidad 
reported that around half of them had symptoms of diabetic neuropathy, 12% had a history of diabetic 
foot, and 4% had to undergo amputation.(63) One study conducted in Barbados reported that the 
cumulative incidence of diabetic retinopathy in people with T2DM was 32% over a four-year period and 
rose to 40% over a nine-year period.(64,65) Another study conducted in Barbados showed that the 
incidence of lower extremity amputation (LEA) on diabetic foot was 936 per 100,000 persons-years, 
these rates are amongst the highest in the world. Compared to North America, European and East 
Asian women, the Barbadian women amputation rates were only surpassed by women in the U.S 
Navajo.(66) A systematic review which included multiple nations (such as Ireland, Spain, USA, United 
Kingdom, Germany, Finland Netherlands and France) identified the incidence of LEA in the diabetic 
population. The incidence of LAE ranged from 78 to 704 per 100,000 person-years.(67) This evidence 
emphases the fact that LEA in Barbados is significantly higher when compared to these nations.   
Based on global projections of T2DM, if action is not taken immediately, there will be a rise in the 
number of complications and this can be very detrimental to the overall productivity of the Caribbean 
region.(65) A study conducted in 2017 highlighted that of the Latin America and Caribbean region 
approximately 79% of the DM population (over 41 million) lived in Latin America and 2% in the English 
Caribbean.(36)  The total cost of DM Latin America and Caribbean region was approximately between 
103-124 billion USD in 2015. English speaking Caribbean indirect cost amounted to 8.3 billion out of 
57.2 billion. Although the overall direct cost of DM was not calculated numbers show that the direct cost 
was also higher in Latin America than the English Caribbean.(36) Other research also emphasised that 
T2DM has a significant impact on Caribbean individuals living with the disease, in particular the  
financial strain. As most Caribbean countries fall under LMICs, universal and accessible healthcare is 
very minimal. T2DM can become very expensive especially since most healthcare payments are out-
of-pocket.(37) 
 
1.9. Rationale- factors leading to poor management of T2DM in the Caribbean 
It is evident by the prevalence of T2DM complications in the Caribbean region that the disease is being 
poorly managed. In the 1990s, two studies reported that the overall quality of care of T2DM patients 
was unsatisfactory in the Caribbean region; more specifically in Barbados, Trinidad, Tobago, Tortola 
and Jamaica.(68,69) Around 50% of T2DM patients in Jamaica had poor glucose control.(68) Of the care 
issues reported, there is inadequate guidance on diet and physical activity, monitoring of blood glucose 
levels, and screening for complications.(64,69,70) 
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Over the years, one of the major concerns expressed by various healthcare providers in the Caribbean 
was the poor management of chronic diseases, including T2DM, which need to be addressed 
urgently.(60,71,72) To achieve healthy results, persons living with T2DM must practice good management. 
However, there multiple factors such as guideline quality and barriers which prevents this from 
happening.  
1.9.1. The quality of T2DM clinical guidelines 
In healthcare, guidelines are used to provide vital information regarding the procedures and resources 
needed to ensure healthcare practitioners provide optimum care to patients  for successful 
management.(46–49) However, although management guidelines have been around for decades the pace 
of implementation by healthcare providers has not been equivalent to the increasing prevalence of 
T2DM.(73) Therefore, the first research study conducted within this thesis is to assess the quality of 
existing T2DM guidelines and also to identify aspects of care included in the guidelines. 
In the Caribbean region, a guideline is available to manage T2DM at the primary care level.(73) This 
guideline was produced in 1995 and updated in 2006.(73) The current 2006 version of the guideline is 
formed for T2DM patients, their families/carers and healthcare professionals whose work involves the 
management of T2DM (such as providers and commissioners). This guideline focuses on patient 
education, lifestyle advice, managing blood glucose levels, managing cardiovascular risk, and 
identifying and managing long-term complications.(73) It was created by the Caribbean Health Research 
Council (CHRC) in collaboration with the Pan American Health Organisation (PAHO) with the aim of 
promoting evidence-based health policy decisions and best practice. The guideline was distributed 
throughout the English speaking Caribbean primary healthcare system, but steered more towards all 
health care practitioners involved in the care of T2DM patients. It was developed based on the economic 
situation, culture and the healthcare systems in the Caribbean region, and was designed to improve 
patient care and reduce morbidity and mortality by effective management of diabetes.(73) Since the 
update of this guideline in 2006, there have been significant advancements in T2DM management; 
therefore, the guideline should be assessed to ensure that it is suitable for use by healthcare 
practitioners.(60)  
1.9.2. Barriers limiting proper T2DM management 
Detecting barriers to T2DM management is vital in improving quality of life and T2DM care, as well as 
creating interventions.(74) Previous empirical research has identified barriers to successful T2DM 
management which included attitude, patients not having enough knowledge about the disease and its 
symptoms and lack of adherence to lifestyle changes.(75) These are aspects of T2DM that should be 
explained and monitored during routine check-ups. The absence of regular check-ups can lead to 
misconceptions, lack of follow up and proper monitoring, which often eventually lead to the high blood 
glucose levels and development of complications.(58) There are many known barriers and facilitators to 
T2DM management identified by individual studies in different geographical locations. However, there 
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is no comprehensive description of barriers and facilitators to T2DM management in the Caribbean. 
The lack of such a comprehensive description can cause challenges when developing and 
implementing T2DM management recommendations and interventions. Since most reviews on barriers 
to T2DM management come from high-income countries, environmental factors (socio-cultural and 
health care) have not been the main focus when developing recommendations and interventions, 
especially in guidelines.(76) Therefore, the second research study conducted within this thesis is to 
summarise the barriers and facilitators of T2DM in the Caribbean. 
 
1.10. Research aim and study objectives 
Although there is a high number of T2DM related cases, complications and issues identified in 
management there is still a lack of research on the topic in relation to the management of T2DM in 
people in the Caribbean. Hence, this research aims to highlight and raise awareness of the disparities 
impacting T2DM management in the Caribbean region to assist with future research, developmental 
plans and strategies. The target audiences for the findings are the various governments, health officials 
and other existing health organisations. It will provide answers to the following questions ‘do healthcare 
practitioners have the appropriate and best quality guidance needed to assist with T2DM 
management?’ and ‘what are the factors hindering or promoting proper T2DM management?’. 
To address the aim as well as identifying responses to the questions outlined, the thesis has taken a 
formative research approach using two methods. This was divided into two chapters: 
1. The first empirical chapter focuses on a critical appraisal of available T2DM management 
guidelines. The most recent Caribbean T2DM management guideline and other international 
guidelines are used to determine what is in the T2DM guidelines and what is their overall 
quality. Comparing all the guidelines will establish what information or knowledge is available 
or not available to health care providers so they are empowered to provide the best possible 
care and assist with T2DM management.  
Objective- The objective was to compare the content and quality of the Caribbean and 
international clinical guidelines for managing T2DM. 
2. The second chapter presents a systematic review of the barriers and facilitators to T2DM 
management in the Caribbean region. All relevant studies on the topic was reviewed and this 
resulted in the summary of all the barriers and facilitators of T2DM management in the 
Caribbean region. The information generated can be used and made generalisable to all the 
islands 
Objective- The objective was to summarise the barriers and facilitators to T2DM management 
in the Caribbean region. 
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1.11. Theoretical models or framework 
Formative research is used to help inform a program’s development or implementation. This formative 
study would assist in guideline and policy development or adaptation and implementation by gathering 
useful data such as the quality of T2DM guidelines as well as barriers and facilitators to T2DM 
management.(77) Although the methods of the two studies weren’t developed with a theory or framework 
initially, the conceptual framework for guideline dissemination and implementation and the theoretical 
domain framework does align with the scope of this research.(77)  
This study aims to improve the effectiveness of guideline dissemination and implementation strategies 
in improving guideline adherence for T2DM management in the Caribbean. Guideline implementability 
is directly associated with guideline development, specifically creation of guideline content and the 
effective communication of this content, hence exploring the quality of T2DM management 
guidelines.(77) Assessing the quality of the T2DM Caribbean guideline will also assess its guideline 
developmental process. At the end of this assessment, researchers would be able to identify areas 
which are poor and needs addressing. This would improve the Caribbean guideline dissemination and 
implementability to ensure proper management of T2DM.(78) A conceptual framework for guideline 
dissemination and implementation draws on evidence from systematic literature reviews on the 
effectiveness of various behaviour change strategies. This framework will allow researchers conducting 
T2DM clinical guideline quality research to focus on strategies to target T2DM patient.(79)  
The advantage of conducting a theory-based analysis of the barriers and facilitators affecting T2DM 
management by T2DM patients, health care professionals and carers is that it provides a framework 
for comprehensively understanding the relationship between these factors and the patients, health care 
professionals and carers behaviour towards T2DM management. The theoretical domain framework of 
behaviour change is a framework for assessing barriers and facilitators of T2DM management in the 
Caribbean accounts for the overlapping constructs across behaviour change theories and it can provide 
categories to capture the factors that influence successful/unsuccessful T2DM management.(80,81) As a 
result of these frameworks the results from both studies can be successfully linked and can be used to 
and inform policies and its implementation and further empirical research. The results from the 
systematic review could be used to help adapt the other guidelines to be appropriate for the Caribbean 
setting.(79)  
The content of the two empirical research chapters are presented as stand-alone peer-review journal 
articles, therefore there is some repetition in the introduction sections of each research chapter; 
however, these have been kept to a minimum where possible. 
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Chapter 2: Appraisal  
2.1. Introduction 
T2DM is a chronic metabolic condition that has major health, social, and economic consequences.(82) 
Patients with T2DM are known to be at an increased risk for microvascular and macrovascular 
complications (such as diabetic retinopathy, diabetic neuropathy/foot, diabetic nephropathy, coronary 
heart disease, stroke, and peripheral arterial disease), and even death.(83) Approximately 90% of people 
with diabetes mellitus have T2DM. Globally, in 2019, approximately 417 million adults were living with 
T2DM.(1) The prevalence of T2DM in the Caribbean region is approximately 9% and T2DM accounts for 
about 14% of all deaths.(61) The prevalence is 5% higher in the Caribbean than the global average. This 
could be because of the Caribbean’s ethnic makeup, which is predominantly Black or Afro-Caribbean 
with some people of South Asian descent. These ethnic groups are at a significantly higher risk of 
developing T2DM than other ethnicities.(84) 
Healthcare practitioners are recommended to follow clinical guidelines for managing T2DM, which 
should contain the best available evidence on how to support and guide both practitioners’ and patients’ 
decisions on suitable healthcare.(85) Clinical guidelines can improve health outcomes by reducing 
morbidity and mortality and enhancing the quality of life, allow patients to make informed healthcare 
decisions, make new procedures and services available to address healthcare issues, and improve the 
quality of healthcare decisions.(86) Usually, high-quality clinical guidelines reduce the differences in 
clinical practice, encourage the use of effective procedures and services, and cut the use of ineffective 
or less effective procedures and services.(87) Thus, due to the positive impact, a clinical guideline could 
have on health outcomes and healthcare, its quality is of great significance. To ensure its quality, all 
the steps to develop a clinical guideline should be systematically followed.(88)  
In the Caribbean region, a national clinical guideline is available to manage diabetes mellitus by primary 
care doctors, nurses, and allied healthcare professionals.(73) The guideline was first introduced over 25 
years ago and in spite of the most recent upgrade in 2006, research has shown that the quality of T2DM 
care in the Caribbean has not improved.(89) To date, the content and quality of the clinical guideline have 
not been robustly evaluated. Therefore, this study aimed to compare the content and quality of the 
Caribbean to international and country-specific clinical guidelines for managing T2DM. Assessing its 
content will allow for the identification and comparison of information and evidence that supports the 
recommendations. Assessing its quality will allow for the evaluation of the methodological rigour and 
transparency of its development, and this includes precise recording and reporting of the methods and 
procedures.(90) The issues identified during this research appraisal could be used to improve the clinical 




2.2.1. Selection of clinical guidelines for managing T2DM 
To compare the Caribbean diabetes mellitus clinical guideline(73) with other clinical guidelines for 
managing T2DM, nine guidelines were identified a priori to represent a selection of international 
countries from renowned associations. As a result these guidelines were more likely to come from high 
income countries. High income countries and associations in high income countries tend have more 
access to funding and resources to develop a high quality guideline. As the Caribbean is made up of 
mainly LMICs, it was important to use these associations from high income countries as a gold standard 
to make a comparison.(91)  
A systematic review approach was not used as the aim was to compare the Caribbean guideline with 
that of guidelines from renowned international associations. The respective websites of the 
organisations were searched on 13th May 2020 to find the most recent published version. All clinical 
practice guidelines had to meet the eligibility criteria (T2DM, management, adults). All the guidelines 
were available in English. We selected three international guidelines (two published by IDF)(13,46) and 
one jointly published by the United States and Europe(92)), and six high-income country-specific 
guidelines (single guidelines from Australia(93), Canada (94), New Zealand(95), and the USA(96), and two 
from the devolved nations of the United Kingdom (one jointly from England and Wales(47) and one from 
Scotland(97,98)) (see Table 3). 
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Table 3: Outline of selected clinical guidelines for managing T2DM  
Outline of selected clinical guidelines for managing T2DM 
 Publishing 
societies/organisations/associations 
Geography of the 
guideline 
Name of the guideline Last 
updated 
1 Caribbean Health Research Council (CHRC) 




Managing diabetes in primary care in the Caribbean 2006 
2 International Diabetes Federation (IDF)(46) International Global guideline for type 2 diabetes 2012 
3 International Diabetes Federation (IDF)(13) International  Recommendations for managing type 2 diabetes in 
primary care 
2017 
4 American Diabetes Association (ADA) and 
European Association for the Study of Diabetes 
(EASD)(92) 
International (United 
States and Europe) 
Management of hyperglycaemia in type 2 diabetes: a 
consensus report by the American Diabetes Association 
(ADA) and the European Association for the Study of 
Diabetes (EASD)  
2018 




General practice management of type 2 diabetes 2016  
6 Diabetes Canada and Canadian Diabetes 
Association (CDA)(94) 
Country-specific (Canada) Diabetes Canada 2018 clinical practice guidelines for the 
prevention and management of diabetes in Canada 
2018 
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7 New Zealand Guidelines Group (NZGD)(95) Country-specific (New 
Zealand) 
Guidance on the management of type 2 diabetes 2011 2011 
8 American Diabetes Association (ADA)(96) Country-specific (United 
States) 
Standards of medical care in diabetes 2020 
9 National Institute for Health and Care 
Excellence (NICE)(47) 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: management 2019 




Management of diabetes: a national clinical guideline 
(SIGN 116 and 154)  
2017 
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2.2.2. Comparison of content of selected clinical guidelines for managing T2DM 
The content of the following topics was compared between the selected clinical guidelines: blood 
glucose management, bodyweight assessment and management, blood pressure measurement and 
management, blood lipids measurement and management, T2DM associated complications 
assessment and management, and other healthcare-related issues and advice, using a previously 
piloted data extraction form. Two independent reviewers (AN and GY) were involved in the process, 
and disagreements were resolved through discussion or with a third reviewer (KC).  
2.2.3. Comparison of quality of selected clinical guidelines for managing T2DM  
The quality of the selected clinical guidelines was assessed independently by two reviewers (AN and 
GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool, which is a 
standardised and validated instrument.(90) The tool comprises of 23 items, separated into six domains 
(scope and purpose, stakeholder involvement, rigour of development, clarity of presentation, 
applicability, and editorial independence) and two global rating items (overall quality score and 
recommendation for use in practice).(90)   
Each item within the AGREE II tool was rated on a seven-point scale (from 1 = strongly disagree to 7 = 
strongly agree). Disagreements in scores that varied by ≥3 points were resolved through discussion by 
AN and GY, for scores that didn’t vary or varied by <3 points they remained the same. The following 
formula was used to calculate the score for each domain:  
Obtain score = total of all item scores for two reviewers in each domain 
Maximum possible score = 7(strongly agree) × y(items within domain) × 2(reviewers) 
Minimum possible score = 1(strongly disagree) × y(items within domain) × 2(reviewers) 
Domain score = 
(𝑜𝑏𝑡𝑎𝑖𝑛𝑒𝑑 𝑠𝑐𝑜𝑟𝑒− 𝑚𝑖𝑛𝑖𝑚𝑢𝑚 𝑝𝑜𝑠𝑠𝑖𝑏𝑙𝑒 𝑠𝑐𝑜𝑟𝑒)
(𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑝𝑜𝑠𝑠𝑖𝑏𝑙𝑒 𝑠𝑐𝑜𝑟𝑒− 𝑚𝑖𝑛𝑖𝑚𝑢𝑚 𝑝𝑜𝑠𝑠𝑖𝑏𝑙𝑒 𝑠𝑐𝑜𝑟𝑒)
 × 100 
Clinical guidelines with a median threshold of ≥70% across all the six domains were considered to be 
of high-quality.(99) Clinical guidelines that did not meet this criterion were deemed low-quality.   
When reporting the overall assessment of the guideline, ALN and GY compared their responses for the 
overall quality of the guideline and recommending it for use in practice. If the reviewers scored the same 
or gave the same recommendation, that score or recommendation was reported. If there were 
differences, the reviewers discussed it and came to a consensus. The score or recommendation 




The Caribbean clinical guideline(73) published in 2006 was between five(95) and 14 years(96) older than 
the other selected guidelines. The Caribbean clinical guideline is a 72-page document. It focused on 
diabetes mellitus, which included type 1 diabetes mellitus, T2DM, and gestational diabetes in the 
primary care setting. Two clinical guidelines (country-specific(94,96)) were found to be similar to the 
Caribbean as they focused on diabetes mellitus in general, which included type 1 diabetes mellitus, 
T2DM, gestational diabetes, and diabetes mellitus in children. Seven clinical guidelines focused solely 
on T2DM (three international(13,46,92), four country-specific(47,93,95,97,98)). Three clinical guidelines were 
<100 pages (two international(13,92) and one country-specific (95)), similar to the Caribbean, and six were 
>100 pages (one international(46) and five country-specific (47,93,94,96–98)). One of the country-specific 
clinical guidelines contained two documents(97,98), and this was 211 pages in total. All the clinical 
guidelines looked at primary care as the setting; however, only three clearly stated this (one 
international(13) and two country-specific(94,95)).  
2.3.1. Comparison of content of selected clinical guidelines for managing T2DM 
The clinical guideline from the Caribbean scored well in terms of including a wide range of topics on 
blood glucose management, bodyweight assessment and management, blood pressure measurement 
and management, and T2DM associated complications assessment and management but generally 
scored less well for blood lipid measurement and management and other healthcare-related issues and 
advice, where limited information was mentioned (Table 4). Comparing the country-specific clinical 
guideline from the Caribbean with those from international and high-income countries, the guideline 
from the Caribbean was found to contain similar levels of T2DM management topics compared to seven 
guidelines (two international and five country-specific guidelines) and contained higher content (>27/44 
items) levels than the remaining two guidelines (one international and one country-specific) (<20/44 
items) (Table 4).
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Table 4: Comparison of content of selected T2DM management clinical guidelines 
Comparison of content of selected T2DM management clinical guidelines 
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Healthy diet 
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Monotherapy (one oral 
drug)b 
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Dual therapy (combination 
therapy, including oral 
drugs and insulin)c 
          
Triple therapy 
(combination therapy, 
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only) 
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Diabetic nephropathy 
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Cancers …  … …   … …   
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Fasting, including during 
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Driving  … … … … 
  
… … …  
 
Holiday/travel … … …  
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Working/shifts … … … … … … … … … … 












Found as a heading or sub-heading in the guideline. 
Limited information (i.e., briefly mentioned in the guideline but not as a heading or sub-heading). 
… Not found in the guideline. 
a Medical nutrition therapy is a therapeutic approach for treating T2DM and its symptoms by using a specifically tailored diet devised and monitored by a medical 
doctor or registered dietitian/nutritionist.  
b Monotherapy is the initial treatment regimen with one oral drug, usually metformin.  
c Dual therapy is when a second drug is added where one drug for T2DM is not managing a person's blood glucose. 
d Triple therapy is when a third drug is added were two drugs for T2DM are not managing a person's blood glucose. 
e Anti-obesity drugs are also known as weight loss medications that reduce or control bodyweight. 
f Bariatric/metabolic surgery is a weight loss surgery that is used as a treatment for people who are very obese and to reduce the risk of other diseases such as 
metabolic or cardiovascular disease complications. 
g Sexual dysfunction in men and women includes low testosterone in men and vaginal dryness in women, respectively.
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2.3.2. Comparison of quality of selected clinical guidelines for managing T2DM  
The clinical guideline from the Caribbean scored less than 70% for all the domains(73) (Table 5). The 
lowest score of 3% related to the rigour of development, and the highest score of 64% related to 
stakeholder involvement. The overall quality score for the clinical guideline was 3. When comparing the 
domain scores to the selected clinical guidelines, the majority of guidelines scored 70% or more for the 
clarity of presentation (8 out of 10)(13,46,47,92–94,96,97). However, less than half scored 70% or more for 
other domains(47,894,97,98). The overall quality score for the clinical guidelines ranged from 2(13,46,73,92–96) 
to 7(47,91,92), with seven out of the nine scoring higher than the clinical guideline from the Caribbean. 
With regards to recommendations for use in clinical practice, the clinical guideline from the Caribbean 
was not recommended for use; additionally, two further guidelines were also identified for not 
recommended for use (one international(92) and one country-specific(95)). Four clinical guidelines were 
recommended for use with modifications (two international(13,46) and two country-specific(93,96)) and the 




Table 5: Comparison of quality of selected T2DM management clinical guidelines 
Comparison of quality of selected T2DM management clinical guidelines 














































































































































Country-specific (CHRC/PAHO)(73) 58% 64% 3% 58% 38% 50% 3 No 
International (IDF)(46) 67% 53% 30% 94% 63% 21% 4 
Yes, with 
modifications 
International (IDF)(13) 100% 61% 23% 94% 35% 4% 4 
Yes, with 
modifications 
International (ADA/EASD)(92) 67% 50% 33% 92% 48% 46% 3 No 




Country-specific (Diabetes Canada/CDA)(94) 94% 94% 85% 100% 73% 71% 6 Yes 
Country-specific (NZGD)(95) 25% 42% 16% 58% 31% 25% 2 
No 
 
Country-specific (ADA)(90) 69% 64% 51% 100% 65% 46% 5 
Yes, with 
modifications 
Country-specific (NICE)(47) 100% 92% 99% 97% 92% 67% 7 Yes 
Country-specific (SIGN)(97,98) 100% 100% 91% 97% 92% 92% 7 Yes 
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2.4. Discussion  
This study has identified that the country-specific clinical guideline developed for the Caribbean in 
2006(73) contained similar or higher levels of relevant content to selected international and high-income 
country-specific guidelines; however, the quality of guideline from the Caribbean was poor and 
therefore, cannot be recommended for use in clinical practice. We identified several high-income 
country-specific clinical guidelines were of sufficient quality to be recommended for clinical practice, 
with similar levels of content to that in the country-specific guideline from the Caribbean.(47,94,97,98) 
However, the quality of the two international clinical guidelines was moderate and hence, recommended 
for use in clinical practice with modifications. The other international clinical guideline was of poor quality 
and therefore, was not recommended for use in clinical practice. Other studies have highlighted that 
although the guidelines address the same health issues, there is variation in the content.(100) In our 
study, we found that although clinical guideline for the Caribbean and several of the comparator 
guidelines referred to most of the relevant topics, a few subtopics were missing in some guidelines; 
which is a common finding with other T2DM management guideline appraisal studies.(100,101) Subtopics 
such as triple therapy, bariatric/metabolic surgery, lipid profile, peripheral arterial disease, periodontal 
disease, cancers, sexual problems in men and women, immunisations for influenza, hepatitis B, 
pneumonia, bacteremia and meningitis, older people, fasting(Ramadan), driving, holiday/travel, 
insurance, and working/shifts were missing from the Caribbean clinical guideline. It should be noted 
that the content of a clinical guideline in itself is not enough to be named as a good quality guideline 
and the guideline development process plays a vital role.(102)  
A high-quality clinical guideline can aid in the clinical decision-making process and delivery of high-
quality care to T2DM patients in the Caribbean(103); however, the development of the guideline depends 
on the availability of resources and following a robust development process.(104) Low-quality clinical 
guidelines can have non-evidence-based, incorrect, contradictory, or not easily identifiable content (and 
recommendations)(102); thereby, impacting on healthcare practitioners’ decision-making, which can lead 
to significant variation in T2DM management.(86) Thus, low-quality clinical guidelines can lead to the use 
of ineffective interventions, inefficient use of scarce resources, and most importantly, harm to 
patients.(90,105) Furthermore, the implementation of clinical guidelines can be challenging due to the 
influence of a complex set of factors, including political, economic, social, cultural, organisational, and 
technical factors, and the influence patients and the public.(106,107) 
Similar to previous research(87,101,103), we found that two domains, rigour of development and editorial 
independence, scored poorly for the Caribbean country-specific clinical guideline and seven of the nine 
comparator guidelines; thereby, highlighting this is an area that is generally neglected and requires 
attention. None of the domains in the country-specific clinical guideline from the Caribbean scored 
highly, resulting in an overall low-quality score. To improve the quality of this clinical guideline, it is 
important that it is updated by following a rigorous guideline development process.(88) Additionally, 
although the Caribbean clinical guideline was first produced in 1995, it was last updated more than a 
 30 
decade ago, in 2006. The guideline was originally developed after taking into consideration the 
characteristics of the Caribbean population, including their economic, social, and cultural conditions, 
and the healthcare systems; however, most of these factors have changed over the intervening 
period(108–110), and therefore, these need to be taken into consideration when future updates are 
performed.   
As a result of the Caribbean T2DM guideline being low-quality, there has been deep consideration on 
weather a new T2DM management guideline should be developed or if an existing high-quality guideline 
from this study should be adapted. Evidence shows that guideline development teams in a limited 
resource settings often work with significantly less technology as well as human resources and budget 
restrictions, which is similar to the Caribbean, makes the development of a new guideline less efficient 
or feasible. However, guideline adaptation is being used as an alternative to developing new guidelines 
as we are able to tailor high-quality international or national guidelines based on the organisational, local 
and cultural settings of the Caribbean.(111) According to the ADAPTE Collaboration Network, who’s aim 
is to promote the development and application of clinical guidelines through the adaptation of existing 
clinical guidelines, the stages of the adaptation processes are grouped into 6 stages.(111,112)  
1.Search for existing guidelines 
2. Assessment of guideline quality 
3.Assessment of applicability and adaptation of 
recommendations to target setting 
4. Literature update 
5. Adaptation of guideline format 
6. Implementation (111,112) 
It is important to note that the needs of the Caribbean clinical guideline development team, topic and 
setting should be considered without compromising rigour and transparency of the guideline.(111,113) 
Following these steps will lead to the improvement of guideline implementation in the Caribbean.(112) It 
should be noted, however there is no validated process for trans-contextual adaptation (the adaptation 
of guidelines produced in one cultural and organizational setting for use in another) present in the 
literature. 
 
A strength of this study is that a recognised and validated tool was used to assess the quality of the 
clinical guidelines. The AGREE II tool was developed to address the variability in guideline 
quality(90,99,101,103,114), and is recommended by the World Health Organisation (WHO), the Guidelines 
International Network, and the Council of Europe for its reliability in appraising clinical guidelines.(115) 
However, there are some limitations. The selection for clinical guidelines was not systematic which 
could have resulted in a biased sample of guidelines being chosen, however we attempted to overcome 
this by choosing a range of renowned international associations. Therefore, this process should have 
minimised the potential for inadvertently identifying low-quality clinical guidelines. Another limitation was 
that all the comparators guidelines were from high-income countries, two of which were considered to 
be of low-quality. The reviewers using the AGREE II tool did not receive any formal training; however, 
this should have had minimal impact on the findings of the study because a robust method of piloting 
of the tool first was conducted and discrepancies and disagreements were discussed with a third 
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reviewer. Therefore, it is unlikely that this would have resulted in a systematic bias in our scorings and 
the findings of the study.  
 
2.5. Conclusion 
The content and quality of the Caribbean clinical guidelines for managing T2DM was found to contain 
a high level of content with regards to relevant topics but was of insufficient quality to be used in clinical 
practice. Therefore, an existing high-quality clinical guideline (e.g. SIGN) as identified within this study 
should be adapted and used for the clinical management of T2DM within the Caribbean.  
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Chapter 3: Systematic Review 
3.1. Introduction 
T2DM is a chronic condition characterised by high blood glucose levels in the body.(9,14) As a result of a 
constant increase in the prevalence of T2DM, it is rapidly becoming an epidemic in many countries.(32) 
There are multiple risk factors associated with T2DM, and the more risk factors a person has, the more 
likely they are to develop T2DM.(2,17) Some of the common risk factors are ethnicity (South Asian, 
African-Caribbean/Black African origin and Chinese people are at higher risk), increasing age, a family 
history of T2DM, unhealthy diet, physical inactivity, overweight or obesity, dyslipidemia, hypertension, 
a history of gestational diabetes in woman and pre-diabetes.(2) Its chronic hyperglycaemia is associated 
with long-term complications (macro- and micro-vascular) and even death.(28) T2DM is also associated 
with reduced quality of life and life expectancy.(30) T2DM places a substantial burden on patients and 
their families and caregivers as well as on a country’s economy and the healthcare system.(32) The 
general T2DM management strategy includes patient education, lifestyle advice, managing blood 
glucose levels, managing cardiovascular risk, and identifying and managing long-term complications.(2) 
If T2DM is detected and managed as early as possible, people with T2DM can live longer healthier 
lives.(116) 
T2DM is one of the most contemporary and important public health challenges in the Caribbean 
region.(61) In the region, 95% of people living with diabetes have T2DM.(9,14,73) The prevalence of T2DM 
is roughly 9% in the region.(60) T2DM patients in the region have poor glycaemic control and high T2DM 
related complications.(68) T2DM is responsible for about 14% of all deaths in the region.(60) Most of the 
associated morbidity and mortality occurs in adults between the age of 18 and 59 years.(61) T2DM 
negatively affects the economic growth and overall productivity of the region. The quality of care of 
T2DM patients is unacceptable in the region and this includes inadequate guidance on diet and physical 
activity, monitoring of blood glucose levels and screening for T2DM related complications.(68,71)   
Several studies have been conducted in the Caribbean region on barriers and facilitators to T2DM 
management.(68,72,117–122) Some of the barriers identified were poor access to health care, difficulty in 
maintaining behaviour change, negative attitudes about living with T2DM and lack of support from family 
members. There have been systematic reviews on T2DM management conducted in other regions. 
Although their some of the theme names were different the reviews identified similar results. In Nigeria, 
factors such as non-adherence/non-compliance, self-care, psychological, social, cost and drugs 
resulted in poor patient health outcome such as elevated glycaemic levels, poor self-management skills, 
early development of DM complications, and loss of trust in clinical management as well as high 
mortality rate.(123) In another systematic review which included studies mainly from the US and UK, the 
patients shared similar factors as in Nigeria as well as limited education, emotions and reliance on 
medications. The clinicians struggled to meet treatment targets due to limited time and resources, they 
also lacked confidence in knowledge of guidelines and skills to assist with T2DM management. Their 
emotions due to frustrations over patient compliance to treatment were also barriers to T2DM 
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management.(124) Lastly a study conducted in Latin America and the Caribbean identified factors related 
to the “environmental context and resources”, “social influences” and “social/professional role and 
identity”  and patients beliefs as important barriers to T2DM management. It highlighted health care 
access or lack of resources in the health system, living conditions of the patients, negative impact of 
lack of support from family and friends and clinicians’ paternalistic attitude.(76) We searched MEDLINE 
and EMBASE, and no systematic review has been conducted on this topic. The systematic review 
aimed to synthesise existing barriers and facilitators, which can occur at the patient level, family/carers 
level and healthcare professional level. Considering the region’s unique socio-cultural structure and 
lifestyle, high burden and poor management of T2DM,(37,64,66,70) it was necessary to undertake this 
systematic review to know whether the perspectives in the region are the same or different from a global 
perspective. This systematic review might help the health experts to take appropriate actions to address 
the barriers and promote the facilitators. 
 
3.2. Review question  
What are the views, experiences, attitudes, understandings, perceptions and perspectives of  T2DM 
patients, their families/carers and healthcare professionals regarding the barriers and facilitators to 
T2DM management? 
 
3.3. Inclusion criteria  
3.3.1. Participants  
This review considered studies that were conducted among adult patients (aged 18 and above) with 
T2DM, their families/carers (a person who looks after a T2DM patient) and healthcare professionals 
whose work involves the management of T2DM (such as providers and commissioners). This 
stakeholder group was most suitable to give the most accurate account of T2DM management. 
Healthcare practitioners provide healthcare (diagnosis and treatment) and advice/knowledge to T2DM 
patients including ways to manage their T2DM. T2DM patients are diagnosed with T2DM and would be 
able to give account of self-management. Family and carers of the T2DM patients provide care and 
support as they have immediate contact with T2DM patients. 
3.3.2. Phenomena of interest 
This review considered studies that focused on the views, experiences, attitudes, understandings, 
perceptions and perspectives regarding the barriers and facilitators to T2DM management. 
Operational Definition of T2DM management 
 34 
According to NICE, T2DM management “focuses on patient education, dietary advice, managing 




The following countries were considered to represent the Caribbean: Anguilla, Antigua and Barbuda, 
Aruba, The Bahamas, Barbados, Bonaire, British Virgin Islands, Cayman Islands, Cuba, Curacao, 
Dominica, Dominican Republic, Grenada, Guadeloupe, Haiti, Jamaica, Martinique, Montserrat, 
Netherlands Antilles, Puerto Rico, Saint Kitts and Nevis, Saint Barthelemy, Saint Lucia, Saint Vincent 
and the Grenadines, Sint Maarten/Saint Martin, Trinidad and Tobago, Turks and Caicos Islands, US 
Virgin Islands.(125) In the Caribbean region, any study setting was considered such as community, 
primary care, secondary care and tertiary care. 
3.3.4. Type of studies 
The review considered studies that focused on qualitative data, including, but not limited to, designs 
such as phenomenology, ethnography, grounded theory and action research. We also considered 
include cross-sectional surveys where free text relating to the review question were reported within the 
paper. Qualitative systematic research are known for investigating the culture and social phenomena 
of communities, exploring how persons experience, perceive and manage their health and journey 
through the health system. It can also assist with evaluating components and activities of health 
services such as health promotion and community development and informs important aspects of 
evidence based healthcare such as T2DM management.(126,127)  
 
3.4. Methods  
The systematic review procedure adhered to the Preferred Reporting Items for Systematic reviews and 
Meta-Analyses (PRISMA)(128) and the Joanna Briggs Institute (JBI) methodology for qualitative evidence 
systematic reviews guidelines.(129) It followed a published protocol.(130) The systematic review was also 
registered with PROSPERO (CRD42018097242). 
3.4.1. Search strategy 
An initial limited search was carried out in MEDLINE and EMBASE databases using the initial keywords, 
and the keywords were type 2 diabetes, management, barriers, facilitators and Caribbean. The titles 
and abstracts of the studies were screened for the same keywords used for the initial limited search, 
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and the index terms used to describe the article were also identified. The search results were inspected 
to ensure that the relevant articles were identified. 
We searched a wide range of sources, to find both published and unpublished studies. For published 
studies, the following databases and their platforms were searched from their inception dates to 11th 
March 2020: MEDLINE (OVID), EMBASE (OVID), CINAHL/BNI (EBSCOhost), PsycINFO (OVID), 
AMED (OVID), Web of Science and Scopus (Elsevier). The full search strategies for all databases are 
detailed in Appendix III. These search strategies were developed through consultation with an 
information specialist/librarian at the University of Nottingham. The search for grey literature 
(unpublished studies) included EthOS (British Library), OpenGrey and ProQuest Dissertations and 
Theses (ProQuest), which were searched from their inception dates to 11th March 2020. The reference 
list of all primary studies included in the review was screened for additional studies. We restricted to 
the following six official languages of the Caribbean; English, Spanish, French, Dutch, Haitian Creole 
and Papiamento.(125)   
3.4.2. Study selection 
Following the search, reviewer one collated all citations that were identified and uploaded into EndNote 
X8.2 (Clarivate Analytics, PA, USA), a reference management software. Reviewer one then removed 
all the duplicates. Titles and abstracts were independently screened by two reviewers for eligibility using 
the inclusion criteria. Identified studies that were potentially eligible or those without an abstract had 
their full-text retrieved by reviewer one. Full-text of the studies were assessed against the inclusion 
criteria by the two reviewers independently. Full-text studies that did not meet the inclusion criteria were 
excluded. The reasons for exclusion were reported. A third reviewer was required when disagreements 
between the two reviewers did not reach a consensus through discussion. 
3.4.3. Assessment of methodological quality 
All the included studies were critically assessed using the qualitative standardised critical appraisal tool 
downloaded from JBI SUMARI.(129) The JBI critical appraisal checklist for qualitative studies used a 10 
question criteria. The checklists used a scoring system, and each domain was scored as either being 
met (Yes), not met (No), unclear (U) or not applicable (N/A). Data extraction and synthesis were 
conducted for all studies which met the inclusion criteria regardless of their methodological quality. 
High-quality, as well as low-quality studies, can generate potentially valuable insights. Together, they 
can lead to a richer understanding of the research phenomenon.(129,131) Two independent reviewers 
were involved in the process. There were disagreements which surfaced between the two reviewers 
and they were all resolved through discussion. A third reviewer was not required to resolve 
disagreements. 
 36 
3.4.4. Data extraction 
The data extraction was undertaken independently by two reviewers. Any disagreements between the 
two reviewers were resolved through discussion. When a consensus was not reached, a third reviewer 
was required. A data extraction and critical appraisal database (using Microsoft Excel), based on the 
JBI System for the Unified Management, Assessment and Review of Information (JBI SUMARI) 
(Joanna Briggs Institute, Adelaide, Australia) was developed and used for the full text studies retrieved. 
We extracted study characteristics – authors, year of publication, study title, study period, inclusion and 
exclusion criteria, study design/methodology, phenomena of interest, country and context, participants 
(T2DM patients or their families/carers, healthcare professionals), sample size, recruitment methods, 
data collection, data analysis and authors’ conclusion. The specific study findings – barriers and 
facilitators to T2DM management in the Caribbean region were extracted for the different population 
groups (patients, family/carers and healthcare professionals). We extracted themes which were 
recorded as findings and direct quotes from participants which were recorded as illustrations. These 
were discovered through repeated reading of the results of the included studies. Reviewers searched 
for (i) any bold text and italic text, tables and diagrams; (ii) data in the form of themes, metaphor or rich 
descriptions; and (iii) keywords such as themes, sub-themes, phrases, categories, quotes, barriers and 
facilitators to T2DM management. The data extraction is detailed in Appendix IV. Credibility of each 
finding was also assessed independently by two reviewers. When disagreements surfaced between 
the two reviewers, they were resolved through discussion. When a consensus was not reached, a third 
reviewer was involved. The levels of credibility are shown in Table 6. 
Table 6: Levels of credibility 
Unequivocal (U) The finding is accompanied by an illustration that is beyond a reasonable 
doubt and is not open to challenge. 
Credible (C) The finding is accompanied by an illustration that is lacking a clear association 
with it and is open to challenge. 
Not supported (N) When neither unequivocal nor credible can be applied and when the most 
notable findings are not supported by the data. 
 
3.4.5. Data synthesis 
Quotes detailing the views, experiences, attitudes, understandings, perceptions and perspectives of 
the barriers and facilitators to T2DM management were also extracted to support the findings. The 
illustrations and findings were the exact words of the participants and authors, respectively, which was 
located in the results of the included studies. All the extracted findings from the three different 
populations were synthesised to develop a core set of synthesised statements.  
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The qualitative study findings from all the studies were pooled using the meta-aggregation 
approach(129,127),
 
it involved the compiling of all findings irrespective of the level of credibility ( U, C, N) 
and categorising them on the basis of similarity in meaning. The researchers adapted the JBI meta-
aggregation approach which normally only includes findings with unequivocal or credible findings, by  
also including non-supported findings. The reviewers done this to ensure that the phenomena of interest 
were clearly described. A meta-aggregative approach produces synthesized action statements (e.g. 
recommendations) to be followed or used by health care professionals and policy-makers. It does not 
aim to re-interpret the results from original research studies as do other qualitative evidence synthesis. 
However, it does aim for a reliable representation of the results from primary research and provides an 
easily accessible overview of the high-quality, qualitative evidence published for researchers, 
healthcare professionals, and policy-makers. The pragmatic approach ensures the practicality and 
immediate usability the review’s findings.(132-134)  
The categories (compiling of findings) were then subjected to a synthesis in order to produce a single 
comprehensive set of synthesised findings. Three reviewers were involved in data synthesis, the 
synthesis of findings was done initially by one reviewer (AN) and then discussed with two additional 
reviewers (KC and JL). One reviewer (AN) compiled all the similar findings into categories. Each finding 
was written on a separate label, the ones that were related were grouped and given a name or 
description which represented them all. This was an iterative approach until an agreement between all 
three reviewers (AN, KC JL) was achieved. All three reviewers (AN, KC JL) then reviewed the 
categories to ensure that all the findings were placed appropriately. Reviewer one then grouped all 
similar categories to make synthesised findings. All the reviewers (AN, KC JL) met again to review the 
synthesised findings and to create appropriate statements to represent each one. When there were 
disagreements, they were resolved through discussion with all three reviewers (AN, KC JL). The entire 
meta-aggregation process took approximately 8 hours, including three 60 minutes of group meetings. 
3.4.6. Assessing certainty in the findings  
The final synthesised findings were graded according to the ConQual approach for establishing 
confidence in the output of research synthesis and presented in a summary of findings table.(135) The 
table includes the major elements of the review and the justification of the ConQual score reported. The 
table also includes the title, population, phenomena of interest and context for this systematic review. 
Each synthesised finding from the review was presented along with the type of research informing it, a 
score for dependability, credibility and the overall ConQual score. Figure 1 and Figure 2 shows how a 
score for dependability and a score for credibility is developed respectively.  
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Figure 1: Dependability score development 
 
Figure 2: Credibility score development 
 
3.5. Results 
3.5.1. Study inclusion 
Following the literature searches, 1322 records were identified. After duplicates were removed, 777 
records were screened for eligibility. Following title and abstract screening, a further 671 records were 
excluded, leaving a total of 106 eligible for full-text screening. Eight studies were identified as eligible 
for inclusion in the review (figure 3).(121,122,136–141) Ninety-eight studies were excluded at the full-text 
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stage due to either ineligible participants (5 studies), ineligible phenomena of interest (26 studies), 
ineligible study context (39 studies), ineligible study design (18 studies) or the full-text paper could not 
be sourced from the British Library (10 studies, 6 of which were abstracts/poster presentations). 
Reasons for exclusion can be found in Appendix V. 
 
Figure 3: The PRISMA flow diagram 
  
3.5.2. Methodological quality  
Overall, all of the qualitative studies scored highly across the methodological quality domains (Table 
7). The studies overall quality ranged from 80% (8/10) to 100% (10/10) and the majority of quality 
domains individually scoring 100% (8/10). However, two of the quality domains had lower scores. “Is 
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there a statement locating the researcher culturally or theoretically?” (Q6) = 63%, 5/8 studies and “Is 
the influence of the researcher on the research, and vice-versa, addressed?” (Q7) = 25%, 2/8 studies. 
Some of the researchers did not declare the beliefs and values and their potential influence on the 
study, therefore the cultural and theoretical orientation it was not clear. This highlighted the absence of 
theoretical models and/or framework that would informed or guided the study design and interpretation 
of the findings. Most studies did not address the relationship between the researcher and participants, 
examine their role and potential influence during data collection nor reported how events during the 
study were delt with. This reduces the trust worthiness and the ability to replicate or improve the 
research.  
Table 7: Methodological quality of the included studies 
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N: No; U: Unclear; Y: Yes; N/A: Not applicable; JBI Critical Appraisal Checklist for Qualitative Research 
Q1 = Is there congruity between the stated philosophical perspective and the research methodology?; 
Q2 = Is there congruity between the research methodology and the research question or objectives?; 
Q3 Is there congruity between the research methodology and the methods used to collect data?; Q4 = 
Is there congruity between the research methodology and the representation and analysis of data?; Q5 
= Is there congruity between the research methodology and the interpretation of results?; Q6 = Is there 
a statement locating the researcher culturally or theoretically?; Q7 = Is the influence of the researcher 
on the research, and vice- versa, addressed?; Q8 = Are participants, and their voices, adequately 
represented?; Q9 = Is the research ethical according to current criteria or, for recent studies, and is 
there evidence of ethical approval by an appropriate body?; Q10 = Do the conclusions drawn in the 
research report flow from the analysis, or interpretation, of the data? 
3.5.3. Characteristics of included studies  
The eight included studies were published between 2005 and 2019. Two studies were conducted in 
Jamaica(122,138), three in the Dominican Republic(139–141), and the other three were conducted in Puerto 
Rico(136), St. Vincent(137), United States Virgin Islands(121). All of the included studies recruited 
participants with T2DM. The studies recruited participants from diabetes clinics, health care centres, 
community centres, an education programme, private physician’s patient log or self-referral. Seven of 
the included studies explicitly stated that the participants were T2DM patients(121,136–141); however, the 
eighth study recruited participants with either T1DM or T2DM - this study was included in the review as 
99% of the respondents had T2DM.(122) No studies were identified which recruited families/carers or 
health professionals. Six of the included studies used a qualitative design(122,137–141), one used a mixed-
methods design(121) and one reported free text within a cross-sectional survey(136). When exploring the 
methodological approaches, four studies focused on phenomenology(122,137,138,141), the other studies 
mentioned different approaches such as connecting and categorising(139), constant comparative(121), 
formative(140) and descriptive correlation(136). The sample size ranged from 14 to 133 participants with a 
total sample size of 426 participants. Three sampling methods were used in the studies: purposive 
sampling(121,138–141), convenience sampling(136,137) and random sampling(122). Data collection included a 
variety of procedures: focus groups(122,138), semi-structured interviews(121,122,139,141), in-depth 
interviews(140) and questionnaire with open-ended questions (free text).(121,136) The data analysis 
methods used in the studies were thematic analysis(137,139), content analysis(136), inductive 
analysis(140,141), constant comparative method of qualitative analysis(121) and one study used a 
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combination of thematic and narrative analysis.(1139) Two further studies did not state which specific 
analysis method they used; however, they reported using coding and identifying themes.(122,138)  
The included studies focused on different areas of T2DM management, shown in table 8. One study 
focused on physical activity, explored self-efficacy beliefs and outcome expectancies (perceived 
benefits and barriers) as possible social cognitive factors affecting physical activity levels in T2DM 
patients.(136) The second study focused on self-management, diet and medication and how diabetes-
related stress impacted it.(140) The third study covered both self-management and lifestyle, focusing on 
the day-to-day experiences of diabetics and lifestyles that may have caused an onset and progression 
of T2DM, health beliefs, attitudes and knowledge of the population.(138) The fourth study addressed 
medication (treatment), focusing on the reasons for the use of non-prescribable medicines in T2DM 
patients.(137) The fifth study addressed only self-management, where it focused on self-management 
behaviours among T2DM patients and investigated the impact of culture on self-management attitudes, 
knowledge, and behaviour.(121) This study also explored whether there was an association between 
self-management behaviours and patient-level characteristics and the clinical outcome of glycosylated 
haemoglobin.(121) The sixth explored local approaches to cope with the stress associated with T2DM it 
also narrowed in on how the approach impacted T2DM patients lifestyle (physical activity and diet), 
medication and clinic appointments.(141) The seventh study focused on self-management and the role 
social support plays through exploring the types and sources of social support across diabetes 
diagnosis and the self-management experiences of T2DM patients.(139) The eighth sixth study focused 
on two management areas, lifestyle change and glycaemic control through exploring the patients 
knowledge of T2DM, motivational factors, and identified possible barriers to positive lifestyle changes 
and glycaemic control.(122)  
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Table 8: The characteristics of all the included studies  
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3.5.4. Review findings 
Barriers and facilitators of T2DM management  
The synthesised findings collated all barriers and facilitators of T2DM management in the Caribbean 
from the patients’ perspective. None of the included studies identified barriers and facilitators of T2DM 
management from the perspectives of family/carers level or healthcare professionals level. There were 
53 unequivocal findings in total across the studies and three credible findings in total across the studies. 
Only one study(122) included findings which were not supported, which included 17 findings. 
After the aggregation of 77 findings, 23 categories were generated, and following further grouping of 
similar themes, the 23 categories were grouped into six synthesised findings. The synthesised findings 
are as followed: From the participants perspective sociocultural norms, demands and pressures were 
found to impact self-management and general care of T2DM; From the participants perspective 
environmental context and resources were found to impact the management of T2DM; From a patients 
perspective support systems were influential on the general management of T2DM; From the 
participants perspective personal background and circumstances can encourage and limit good self-
management and general management of T2DM; From the participants perspective emotional factors 
were found to influence patients’ actions towards management of T2DM; and from the participants 
perspective psychological factors were found to  influence  patients’ adherence to T2DM management.  
 
Synthesised finding 1: From the participants perspective sociocultural norms, demands and 
pressures were found to impact self-management and general care of T2DM 
Synthesised finding 1 was the result of nine findings which were merged into three categories (Figure 
4). The finding expressed how patients continued to consume local unhealthy foods and traditional non-
evidence based traditional medicines or therapies despite the repercussions. Social stigma included 
the shame and judgement passed from others/community to T2DM patients.  
● Following an unhealthy diet 
Different types of food have different effects on the body of T2DM patients. Participants expressed the 
importance of balancing different foods, including unhealthy foods to help assist in the management of 
their T2DM. 
“… If I feel drowsy, sick and I take some food and throw it in me mouth, it carry the feelings down. But 
if you sugar some tea and drink it, throw you down clean, you see.” (137)p.1495 
Some participants develop their own remedy to tackle different symptoms or conditions associated with 
T2DM in some cases these were not the healthiest options. They also believed some of these foods/ 
remedies had been used in communities for generations, so they are appropriate to use. In some 
instances, participants expressed they continue to eat the unhealthy foods because they have been 
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eating it all their lives and it has not caused any problems to them, neither are they dead yet as a result 
of it. As such, they believe that foods cannot be unhealthy if it does not affect them or their illness 
(T2DM). 
“I take liberty every day. Right now I have … 3 plantains, 5 or 6 tanya, sweet potatoes, and I plan to 
take pig tail and cornmeal dumplings and make a big pot of peas soup…. You know the attitude I 
take. I live 70 years eating the same thing. What, now it’s going to kill me?”(121)p.7 
● Use of traditional non-evidence-based medicines or therapies 
Patients reported the use of medicines and therapies that had no scientific evidence to support and 
prove what it can and cannot do for T2DM management. Different types of ingredients were used to 
make a medicine, which was believed to tackle certain complications associated with T2DM.  
“… If you buy ah egg and you bust it a little and you throw it out in the pan, you know and you beat it 
with some of the milk and drink it … that is a medicine!”(137)p.1494 
As these medicines and therapies are not evidence-based, their efficacy for T2DM management cannot 
be inferred. Patients believed that traditional medicines and therapies were better than conventional 
medicines. These traditional medicines were also passed along throughout the communities and even 
from one diabetic patient to the next. Although patients did not have any scientific evidence on the 
benefits and role of the traditional medicines and therapies, they still consumed them hoping for the 
best results.  
“(My neighbor) is a diabetic too…. Sometimes she buys bush and give me some. I don’t know the 
name of it but it is supposed to help with sugar. So I use that.”(121)p.7 
● Stigma 
Stigma was expressed as a barrier to effective T2DM self-management. Most sicknesses come with a 
stigma attached to it. Peoples reaction to finding out someone has diabetes has resulted in patients 
becoming uncomfortable and secretive about their disease. Patients expressed that a stigma has been 
built around the disease because is not discussed out in the open it.  
“I think this needs to be more out in the open. Because you can have diabetes and control it and do 
everything that everybody else does. But it’s so secretive … everyone will treat you like you’re dying. 
There’s a stigma attached, yes. To being diabetic or having to take medicine for it.”(121)p.7 
The community’s reaction towards T2DM patients shows that they do not have enough information or 
understanding about the disease. It is known that people tend to be afraid of things they do not know 





Figure 4: Synthesised finding 1- From the participants perspective sociocultural norms, 




From the participants 
perspective sociocultural 
norms, demands and 
pressures were found to 
impact self-management and 
general care of T2DM 
 Following an unhealthy diet 
 
Control of diabetes was ascribed 
to a balanced intake of starchy 
foods and different food types 
were utilized to give this balance 
(U) 
 
Cultural nuances shaped 
perspectives of self-
management: Importance of 
maintaining local diet (U) 
 
Use of traditional non evidence 
based medicines and therapies 
 
Use and belief of non-
prescribable medicines (U) 
 
The importance of bitterness in 
diabetes treatment also 
emerged from the findings and 
this was perceived as being 
good (U) 
 
Traditional foods as medicine 
(alternative medicine) (U) 
 
Participants felt that their folk 
medicine had got the better of 
conventional medicine (C) 
 Use of "bush teas" (N) 
 
Cultural nuances shaped 
perspectives of self-
management: use of herbal, 
complementary, and alternative 
remedies (CAMP) (U) 
 Stigma   
Culturally- specific challenges 
were barriers to effective self-
management: stigma (U) 
 55 
Synthesised finding 2: From the participants perspective environmental context and resources 
were found to impact the management of T2DM. 
Synthesised finding 2 was the result of five findings which were merged into two categories (Figure 5). 
Environmental context relates to the actual physical space (such as a venue for exercise/gym), and 
environmental resources can refer to any service, materials or information that a person may find useful 
to them.  
● Safety and wellbeing during physical activity 
Another factor highlighted by T2DM patients which hinders physical activity is the safety. Persons do 
not feel safe travelling to the gym or park to do physical activity because of where it is located. Some 
environments or places are not safe (this may be because of the high crime rate), and people will not 
risk the safety going to these places.  
“Safety in the area. My husband works and cannot go with me.”(136)p.87 
● Lack of resources 
There was a consensus amongst the patients that many resources to aid in T2DM management were 
not available. There was a lack of financial, educational, healthy food options and exercise or physical 
activity options, which all hindered proper T2DM management. It is essential that patients, doctors and 
carers are educated about T2DM and its management. Patients highlighted the lack of educational 
resources for T2DM patients, especially immediately after diagnosis. 
“I think there should be better resources for diabetics. Once you’re diagnosed there should be a place 
that you can go to for regular classes and monitoring. I can’t believe we don’t have that in this day and 
age. There isn’t even a dietician there (doctor’s office).”(121)p.7 
Patients were knowledgeable of the healthy food options, however, they could not afford it, it was too 
expensive. The lack of these resources promotes poor self-management. 
“Making the good food choices is hard. They’re simply not available in stores. Well, sometimes. Now, 






Figure 5: Synthesised finding 2-  From the participants perspective environmental context and 
resources were found to impact the management of T2DM 
 
Synthesised finding 3: From a patients perspective support systems were influential on the 
general management of T2DM. 
This synthesised finding was the result of 13 findings which were merged into four categories (Figure 
6). Support systems may include family, friends, spouses and healthcare professionals. They may also 
offer different types of support such as emotional, informational and instrumental, which consist any 
physical assistance, e.g. financial, childcare and transportation. This finding showed that family, friends 
and health care professionals were support systems. Family and friends had both a positive and 
negative influence on T2DM management. However, health care professionals were perceived to have 
only a positive influence on the management of T2DM.  
● Lack of support from family and friends 
Some patients expressed that their family and friends expected them to continue doing everything by 
themselves as usual with no help, even after being diagnosed with T2DM. They received limited support 
from family and friends which at times can be inconsistent. Also, patients reported that even if they do 
receive some level of support from friends, it is only for a short period and not or the long-term 
management of the T2DM. 
 
 
From the participants 
perspective environmental 
context and resources were 
found to impact the 
management of T2DM 
 
Safety and wellbeing during 
physical activity    
Concerns regarding their own 
safety (U) 
 Lack of resources  
 
Medical homes were rarely viewed 
as a primary source of diabetes 
educated or support: Lack of 
educational resources (U) 
 Economic impact (U) 
 
Culturally- specific challenges were 
barriers to effective self-
management: Limited access to 
healthy food options/exercise (U) 
 57 
“No one supports me, no one. How do I say this, even if I feel bad no one pays attention. Not even my 
sisters come to visit and lend me a hand. But God gives me strength, because no one else helps me. 
What happens is that when my sugar levels go up, I cannot sleep well and sometimes I get scared. 
Sometimes my family does things I don’t like, which makes me feel ill, like I have high blood pressure. 
I don’t know. Listen, those who have diabetes have to be careful and so they need someone who will 
support them so that they feel better.”(139)p.7-8 
● Incorrect/ negative advice from family and friends 
T2DM patients reported that although family members were trying to be supportive by providing help, 
they would advise the patients against the doctor’s orders or give their own advice or recommendations. 
Family and friends were identified as influencers of adjusting the doses of medications. As a result of 
self-adjustment of medications, T2DM cannot be managed efficiently and effectively. 
“Well, the doctor told me to take the insulin two times but my mother tell me I want to know if this is 
right. He tell me to take twenty five units in the morning and twenty five in the night. But she said it’s 
too much, and just gives me fifteen at night. So that’s what I do.”(121)p.7 
● Positive support from family and friends 
Although support from family and friends was a barrier to T2DM management it was also a facilitator. 
Participants expressed how friends were more than willing to offer their help and expertise. Friends 
would ensure that the T2DM patient would adhere to the healthy diet and stick to their self-management 
regime. In addition, friends would invite their T2DM friends to programmes and appointment that they 
thought were beneficial to T2DM patients. At these programmes and appointments, patients are able 
to learn more about their T2DM and its management.  
“How did I first get here? The man sitting in the waiting room brought me. He found out about this 
program and invited a group of us to go with him. Every month a few of us go in his bus for our 
appointments.”(139)p.6 
In addition, neighbours provided instrumental support by taking the patient to the doctor and 
informational support by alerting the patient that they might be ill because of their physical appearance. 
There the doctor was able to provide informational support by making a diagnosis.  
“…She told me, ‘you’re sick, your clothes are loose and falling off of you.’ I agreed. I had a t-shirt that I 
no longer fit in. Dry, I was getting drier, [...to the point that] a man told others ‘be fearful of that man, 
he could have AIDS.’ And I heard that, you see? I went to my partner and told her that I felt ill. After 
that a neighbour took me to the see a good doctor to see about my condition where the doctor then 
tells me, ‘sir, you are a diabetic.”(139)p.6 
● Good support from healthcare personnel 
Participants expressed that male patients tend to avoid doctors making them more vulnerable to T2DM 
complications. However, healthcare professionals provided informational support which entailed 
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medical advice to assist patients who were in distress or having complications and also provided health 
talks on self-management. The support from healthcare personnel is pivotal in T2DM management. 
“For men, we can suffer from a problem with (sexual) relations. I spoke with the doctor when I had a 
problem [erectile dysfunction]. He told me what I need to do to control my sugar otherwise I won’t get 
better.”(139)p.8 
Healthcare professionals also provided emotional support to patients, they spoke to them about their 
problems which helped them to feel better. This allowed patients to get a better perspective of their 
T2DM so that they can cope with it.  
“Before I came here I felt that everything was crashing around me. Some of us feel like we’re 
drowning in a cup of water because we do not find someone to talk to about our problems. But now I 
can talk to the cooperadores…to the doctor, and I feel better.”(139)p.8 
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Figure 6: Synthesised finding 3- From a patients perspective support systems were influential 
on the general management of T2DM.  
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Synthesised finding 4: From the participants perspective personal background and 
circumstances can encourage and limit good self-management and general management of 
T2DM 
This synthesised finding was generated from 11 findings which were merged into five categories 
(Figure 7). Personal background includes a person’s heritage, the level of or kind of education they 
received, and their social and economic status. Personal circumstances are difficulties or issues which 
may impact a person’s ability to accomplish specific tasks. The categories which had a negative impact 
include competing priorities/ physical activity, co-morbidities/ medical history, and inadequate 
knowledge. There are some personal circumstances such as increased knowledge and perceived 
benefits of physical activity which has a positive impact on a person’s ability to accomplish certain tasks.  
● Impact of competing priorities on physical activity  
Physical activity is one method used for managing T2DM. Although the participants are aware of the 
benefits of physical activity, they have expressed that different factors are serving as obstacles to 
physical activity. The most common factor was not having the time for physical activity due to other 
responsibilities.  
“My work demands many times do not allow me to get home early.”(136)p.87 
● Co-morbidities and medical history 
Due to T2DM patients co-morbidities/medical history, their body is limited to certain actions and based 
on their conditions or disabilities. As a result of these limitations, T2DM patients are unable to be 
physically active.  
“When my back condition or knee does not allow me to do it.”(136)p.87 
There are multiple complications associated with T2DM which affects the patients’ body in different 
ways, because of this, patients spirits are dampened and are not their usual selves.  
“It’s not an easy thing. Having diabetes contributes to other sickness and it’s not nice, because it 
become like a part of you gone.”(138)p.75 
● Inadequate knowledge 
It was highlighted by the authors that there was not enough knowledge about T2DM being disseminated 
amongst the patients, which is essential in the management of T2DM. The patients cannot manage 
their T2DM if they have no knowledge about it. There were no quotes or illustrations to represent the 
lack of knowledge. 
● Perceived benefits of physical activity 
Physical activity is an essential form of T2DM management, and all physically able patients should be 
physically active. Patients reported that because of the benefits of physical activity they were more 
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eager to continue being physically active. Patients were able to carry out more tasks in their daily 
activities and their physical well-being was better.  
“I am less tired in my other activities.”(136)p.87 
Being physically active has also allowed patients to form friendships which formed clubs. As a result of 
the social benefits more T2DM patients were encouraged to become physically active. 
“When I exercised outside my house I met new friends and I joined a jogging club.”(136)p.86 
● Increased knowledge 
Participants expressed that because of increased knowledge of T2DM they were more motivated to 
make changes in their lives and manage their diabetes properly.  
The motivation that came after increased knowledge was exemplified by Ophelia who said, “So me 
gets-- me finds out now. So me have diabetes. And from thence on, me started the change. Them 
give me a diet sheet. And them tell me what to eat, and what not to eat, and so-and-so forth. But you 





Figure 7: Synthesised finding 4- From the participants perspective personal background and 
circumstances can encourage and limit good self-management and general management of 
T2DM. 
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influenced the patient’s management of T2DM. The categories which positively influenced the patient’s 
management of T2DM were high mood and high motivation and fear of the disease/ complications.  
● Low mood and low motivation 
Participants reported an overall lack of motivation and interest when focusing on obstacles to physical 
activity. As people were not motivated to be physically active, they were not able to use this form of 
management for T2DM, which is as important as any other form of management. 
“Lack of motivation and interest.”(136)p.87 
Due to the toll T2DM and its complications has on the human body, participants were somewhat 
defeated. Patients also expressed how much they have been suffering and the emotional impact that 
the disease had on them.  
“Ah, diabetes... Whatever I could do first, I cannot do it again…It burdens my body. It’s against the 
body. Walking — I cannot walk straight…The most difficult part is over the body... poor circulation 
too... It look like it caused that too. …me fall down, as me step, me fall down…Yes, the nerves gone 
right out… It burn me under the heel and stick me... It can come anywhere… affecting my foot bottom 
and my heel. It burning me, burning me, burning like pepper...and the eyes, man, I don’t know if it’s a 
glaucoma get in the eye and eat out the eye….I can’t tell you how long I am suffering, 
suffering...”(138)p.77 
● Fear of the disease/ complications 
Patients showed concerns about the complications associated with T2DM and the impact it would have 
on their lives. This hindered them from seeking the appropriate care. Patients were also afraid to visit 
the doctor for check-ups because they were afraid of the doctors and the unknown of their disease 
(information/results they were going to receive). 
“them don’t go for check-ups because them afraid from the doctor."(138)p.91 
● Stress 
Patients reported finding it stressful to adhere to the recommended diet due to accessibility and 
availability of foods. Patients also reported finding it stressful to cope with knowledge that not adhering 
to medication would result in complications associated with T2DM, including death. As a result of these 
stressful scenarios, patients reported not thinking about or dealing with their T2DM management as 
coping techniques. 
“If you have AIDS, HIV, you have treatment. [handclap] Done. If you are in treatment, you can live 100 
years and die of something else—you will not die of that [HIV]. But with diabetes, a person without 
treatment can be sure that one day, he will lose his vision. Through diabetes comes the famous 
diabetic foot or kidney problems. It is a tragedy for them and their family because now you have lost 
everything.”(140)p.860 
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‘‘Living with diabetes is worse . . . when you think about it. It is worse because you can even die of 
depression if you think about that, and [it can affect] your heart and all that..”(140)p.861 
● Denial 
Patients who did not want to accept that they had T2DM was in denial, and because they did not 
acknowledge the disease they did not attempt to manage it. Patients thought it was easier to ignore the 
signs rather than deal with the problem.  
“I don’t want to think about it (having diabetes). Like I say, I don’t say I’m a diabetic. I only say my 
sugar is a little elevated. I don’t even want to call the word.”(121)p.7 
● High mood and high motivation 
Although some patients moods and motivations had a negative impact on their T2DM management, 
some patients reported high mood and motivation. Having T2DM made patients more eager to live a 
healthier lifestyle, more eager to get better and reduced complications. As a result, patients ensure that 
they continue their self-management regime to stay in good health.  
“I feel good and it cheers me up. My self-esteem increases.”(136)p.86 
● Fear of the disease/ complications as a motivator 
Patients reported that the fear of poor health outcomes if T2DM is not managed correctly had motivated 
them to manage their T2DM properly. Participants expressed that they would continue to take good 
care of themselves so that they will never have to suffer or develop any complications.  
“And feeling healthy, that is the best. My mother, when she was alive, she used to take care of us, 
and she take care of herself until she leave us. So that's why I said I would take good care of myself 
just like my mom, and also she take care of her mother.”(138)p.86 
As there are many complications associated with T2DM such as loss of limbs or eyesight. The 
participants expressed the fear of this happening to them. This fear has motivated them to try and 
manage their food intake and eat healthier food options as well as stop unhealthy habits, e.g. drinking 
alcohol.  
“I see the struggle when people lose limbs. I play the flute and don’t want to lose fingers so I 
changed  everything … I stopped the alcohol. And I cut back on all the starchy, Caribbean foods. You 
have to make up your mind that you’re going to back out of all those foods you grew up with. I grow 
my own vegetables now. And that is another way I can get exercise.”(121)p.7 
“My concern about having diabetes is when you read up on it, you'll realize that if you don't take care 
of yourself, you can lose a limb and you can even go blind.”(138)p.74 
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Figure 8: Synthesised finding 5- From the participants perspective emotional factors were found 
to influence patients’ actions towards management of T2DM 
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Synthesised finding 6: From the participants perspective psychological factors were found to  
influence  patients’ adherence to T2DM management. 
This synthesised finding was the result of 19 findings which were merged into three categories (Figure 
9). Personal attitudes are a way of thinking or feeling which is usually redirected or expressed through 
a person’s behaviour. Both negative and positive attitudes are formed based on values, beliefs and 
feelings. However, negative attitudes should be avoided.  
● Positive personal attitudes and thoughts towards the adherence of good T2DM management 
Patients reported that they changed their eating habits to ensure that it coincides with their T2DM 
management. They have done this to avoid depending heavily on medication. Due to their positive 
attitude towards T2DM management, they found it easy to succeed in their T2DM management and 
limit the associated complications.  
“My doctor told me what to eat, so I just stick by that. It's not hard as I cut down on portion size. Good 
eating habit, I can tell you. And why I know as I talk about the medication, I was following people and 
see, you can't get up every day just taking tablet, taking tablet. (138)p.88 
Patients also ensure that managing their T2DM takes priority over everything else. They ensure to go 
to their doctors’ appointments, follow the doctor’s instructions as well as save to purchase their 
prescribed medications as it is expensive.  
“…the medications are very expensive. No matter how small it is, whatever, I have to make sure I put 
that money aside to fill my prescription. I don't put nothing before it.”(138)p.83 
Some patients were able to adhere to a good T2DM management through not thinking about their 
illness and keeping busy in their lives. Thus, using these as coping strategies to maintain diabetic 
control, live normal, happy lives. 
“If you are working, your mind will be busy and you won’t remember that you’re sick. You’ll live your 
normal life.”(141)p.6 
● Positive impact of religion 
Results showed that participants found comfort and emotional support by praying to God. They view 
praying to God as a way of having a conversation to get advice and to feel better about their T2DM 
condition. It lifts their spirits making it easier to manage and deal with their T2DM.  
“If you say you prayers and you go to yuh bedside and you pray you does get yuh own little thing. 
Sometimes one leaf of bush they will tell you to boil and you know! You feel much better.”(137)p.1494 
“You pray a lot about your condition. A way to get comfort.”(138)p.79 
 
● Negative personal attitude towards adherence of good T2DM management 
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Patients struggled to adhere to the management of their T2DM. They did not believe in the prescribable 
medicines, and so they either did not use it or used it irregularly in combination with their own plant/bush 
remedies.  
“The Doctor medicine is useful … I take it today, tomorrow I take the bush.”(137)p.1494 
Taking prescribable medicines, monitoring of glucose and sticking to the regime are essential aspects 




Figure 9: Synthesised finding 6-From the participants perspective psychological factors were 
found to  influence  patients’ adherence to T2DM management  
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This is the first systematic review to summarise the barriers and facilitators to the management of T2DM 
in people from the Caribbean. After an extensive search of the literature, a total of 1322 hits were 
identified. Following best practice methods, eight papers were included in the review. Overall, the 
included studies were of high methodological quality. The included studies focused on patient-level 
barriers and facilitators that affected different aspects of T2DM management (including self-
management) in five different Caribbean countries. However, no findings were identified which related 
to discussing T2DM management from the perspective of family/carers or healthcare professionals. 
The barriers and facilitators identified were sociocultural norms, demands, pressures impact on self-
management and general care of T2DM, environmental context and resources impact the management 
of T2DM, support systems influence on the general management of T2DM, personal background and 
circumstances can encourage and limit good self-management and general management of T2DM, 
emotional factors which influences patients’ actions towards the management of T2DM and 
psychological factors and their influence on patients’ adherence to T2DM management. Four of the 
synthesised findings were considered to be both barriers and facilitators in some areas such as support 
systems, personal background and circumstances, influence of emotions and psychological factors and 
personal attitudes. Among these were themes such as moods and motivation, stress, attitudes towards 
adherence, knowledge, medical history, availability of resources, physical activity benefits and support.  
Physical activity is an integral part of T2DM management(142), and so is ensuring that it is part of patients 
with T2DM management regime. This study showed that the multiple benefits of physical activity, such 
as improvement in a patients’ overall physical and mental health, encourage patients to continue being 
physically active. A study conducted in India contained supporting evidence which revealed that the 
awareness of the benefits of exercise also emerged as a facilitator.(143) Despite the benefits of physical 
activity being a facilitator, there were also barriers associated with physical activity. Patients competing 
priorities made them unable to be physically active. Patients expressed there was too much going on 
in their lives to fit any physical activity into their schedule. It was supported by other studies carried out 
in South Asian populations.(143–146) A study conducted in South Asia found that fear of injury or worsening 
health with exercise was a barrier to T2DM management, which was consistent with the findings from 
this review.(145) In South Asia populations, the lack of gender-specific facilities for physical activity was 
a barrier to T2DM management, however, this was not consistent with this review’s findings.(145) In 
addition, unsafe environments for physical activity was also a barrier to T2DM management in South 
Asia as participants did not want to risk their lives or risk getting hurt going to gyms which were situated 
in dangerous areas.(145) 
This review found that cultural practices influence the diet of patients negatively, two other studies which 
highlighted the barriers to self-management and management of T2DM  (carried out in the Unites states 
and United Kingdom respectively) supported this.(147,124) Cultural demands/pressures showed that 
patients religious beliefs as well as their belief that traditional foods did not aid in the management of 
T2DM management. This result was consistent with one of the overall themes from a study from South 
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Asia. They found that social responsibilities to continue with traditional diet and misconceptions on the 
components of diabetic diet were barriers to T2DM management.(145) This study showed that there were 
many misconceptions about T2DM and its’ management, some findings showed that what patients 
believed about T2DM and its’ management were false or had no scientific evidence to support its’ 
benefit. Some of the procedures followed by patients to manage their T2DM may have been doing more 
harm than good. Stigma is associated with knowledge as it is usually present when there is a lack of 
understanding, hence being grouped into this category. People tend to be afraid of what they do not 
understand or have no knowledge about, and as a result, they do not always adapt to changes.(124,148–
150) Nevertheless, there are cases where patients do adapt to cultural changes such as following 
appropriate dietary advice and exercise regime which facilitates with their T2DM management. This 
finding was supported by other studies across the world, in South Asia, the United States and the United 
Kingdom.(145)  
Participants displayed negative attitudes towards adherence to good management which was identified 
as a barrier. Non-compliance consisted of patients not following doctors’ orders or using prescribed 
medications which managed their T2DM. In a study conducted in the United States, communication 
with healthcare providers was not specifically identified as a synthesised finding. However, patients 
non-compliance to prescribed medication was a barrier to T2DM management.(147) Similar themes such 
as communication discordance with healthcare providers, non-compliance to partake in self-
management, lack of understanding about medication management and prefer for folk and 
phytotherapy (herbal/ traditional medicine) were found by another study done in South Asia.(145) Some 
studies show that non-compliance may have been the result of lack of trust between healthcare 
professionals and patients, lack of knowledge/education, patients’ own beliefs not coinciding with what 
was told or given by healthcare professionals, and not being able to follow the regimen or not being 
able to afford the appropriate healthy food or services.(145,151,152) In this study, there was no illustration 
or theme which highlighted trust in health care providers as a facilitator or lack of trust in healthcare 
providers as a barrier to T2DM management. However, this does not mean that it does not exist, as 
one study showed that trust in health care providers was a facilitator to T2DM management.(145)  
There were some positive attitudes towards T2DM management adherence where patients expressed 
the importance of following the doctors’ orders, taking their medications, adopting a diabetic diet and 
ensuring that they were managing their T2DM to the best of their ability. Fear was presented as a barrier 
and facilitator to T2DM management. Fear as a barrier was supported by Byers et al.(152) however it did 
not support the findings of fear being a facilitator, participants expressed that the fear of complications 
was not enough to motivate them to adhere to good T2DM management.  Patients have also used their 
moods and own self-motivation as a barrier and facilitator to negatively and positively influence their 
T2DM management. Barriers entailed patients not wanting to control their diet and having no motivation 
to keep healthy. Facilitators entailed patients wanting to live and stay healthy. 
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Support was identified as both a barrier and a facilitator to T2DM management depending on the 
circumstances. The support as a facilitator was the richest finding, it had the most themes and many 
illustrations to support the themes. It also outweighed support as a barrier by having more positive 
outcomes than adverse outcomes with regards to supports’ influence on T2DM management. The 
facilitators proved that there was support given to patients from immediate and extended family, 
spouses, friends, neighbours and healthcare professionals. Family support and were facilitators that 
were consistent in both the Caribbean and South Asia. There was emotional, physical, informational 
and instrumental support provided to T2DM patients, all of which helped with their disease 
management. A driving force of this could have been that these persons cared for the patients and 
wanted them to have the best possible health outcome. Studies have supported the importance of 
support as a barrier and a facilitator.(143,148,152–156) However, it is also important to note that there was no 
comments/ evidence that the support from healthcare professionals had a negative impact on T2DM 
patients’ management. 
However, the patients also identified some barriers associated with support. One of these barriers was 
“a lack of emotional support from a cohabitating partner”, this could have been anyone living in the 
patient’s household or with them. Another barrier was that “support from friends and neighbours were 
less prominent in the long-term management stage than the support from partners and providers”. One 
main reason for the occurrence of these barriers could be lack of knowledge. It could be that persons 
do not know what is required of them when providing support, how long it is needed for and how to give 
support correctly. It cannot be said for sure what type of support was given more than the other or who 
gave more support than the other, but from the results, it can be said that support was more of a 
facilitator to T2DM management than a barrier.(157–160) A study done in the United States identified a 
lack of active support groups as a barrier to T2DM management.(147) This study did not identify any 
illustrations or themes where support groups were mentioned. This may be because there are none 
available or patients are not aware that there are support groups available. 
Knowledge was identified as a barrier and a facilitator to T2DM management. Increased knowledge of 
T2DM was identified as a facilitator. Any knowledge, whether it is big or small, it is essential. A study 
done in the United States reiterated that “personal understanding of T2DM” was a facilitator T2DM 
management.(147) However, there was an overall lack of educational resources on T2DM and its 
management. The lack of educational resources may have been the result of healthcare professionals 
not knowing the information to deliver to patients or inappropriate medium used to deliver the 
information. Although one finding stated that some patients acquired knowledge about diabetes, it was 
done after they began treatment for the disease. Realistically, information on T2DM should have been 
provided on the diagnosis of the disease, however, this was not the case.(74) Lack of knowledge may 
have also lead to patients’ non-compliance. Studies which focused on South Asia, the United States 
and the United Kingdom also identified lack of knowledge as a barrier to T2DM management.(145,124) 
The language barrier between T2DM patients and healthcare providers was identified as a T2DM 
management barrier in studies conducted in South Asia and the United States but not in the 
Caribbean.(145,147) Language may not have been a barrier in the Caribbean because the healthcare 
 72 
providers speak the first language of the country, in most cases this is English. Whereas in countries 
such as South Asia and the United States, both patients and healthcare providers may speak different 
languages as they are more likely to have different backgrounds. 
The study done in the United States showed that the lack of other resources in the local community 
was a barrier to T2DM management.(147) In the Caribbean, unsafe environment for physical activity and 
lack of resources such as affordable healthy foods and medicines and the poor infrastructure to exercise 
were all additional factors that were as barriers to T2DM management.(143,158,161) Despite the patients’ 
wanting to follow good T2DM management practices, the resources were not available. For example, 
although healthy foods are available in the Caribbean people could not access it due to the high cost 
of living. It must me highlighted that key areas of self-management (e.g. footcare) were not mentioned 
at all by the participants in this research, indicating that more research is needed to focus on this area 
of T2DM management. 
Most of the themes/categories are connected to some degree. For example, being educated or having 
knowledge about T2DM may affect or change people’s belief, views and understanding of the disease’s 
management. It can determine whether patients comply with their doctor’s instructions, stick to their 
prescribed medications in addition to knowing what is required when giving support. This shows that 
knowledge can eliminate more than one barrier. There were many similarities in the barriers and 
facilitators to T2DM management when compared to the literature. Although some themes such as 
“personal understanding of T2DM” and “Knowledge of T2DM” were described differently or had a 
different heading, their illustrations were similar, and they all came under the same category/ theme. It 
is now evident that many of the barriers faced in the Caribbean are being faced in other countries, such 
as South Asia, the United States and the United Kingdom. However, there were some barriers which 
were identified by patients in other geographical regions but not in the Caribbean. In the Caribbean 
patients did not express the lack of time spent with physicians and empathy as a barrier to T2DM 
management, but it was in South Asia. Another barrier T2DM management identified in South Asia was 
cold weather being a hindrance to physical activity, however, this was not a barrier in the Caribbean. 
This difference may be the result of geographical location, different cultural background, level of the 
health care system and health care provided, resources available to healthcare providers and patients 
and the country’s economy.  
3.6.1. Strengths and limitations 
This study has several notable strengths. The study was carried out using two independent reviewers 
throughout, which helped to reduced bias from occurring. The level of confidence of the study findings 
generated were moderate to high. It showed that the results were reliable, accurate and could be 
trusted. Out of 28 islands in the Caribbean, the six studies in this systematic review was conducted in 
five Caribbean islands (Puerto Rico, St. Vincent, Jamaica, Dominica Republic and United States Virgin 
Islands). Although the islands all share similar culture on the surface, they all differ in their unique way. 
Every island has been influenced by its colonisers or immigrants and as a result the Caribbean is made 
up of different ethnicities and each island ethic make up is different. Every island has its’ own unique 
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national(main) dish which is made up of different ingredients that are grown or can be found on all the 
islands. This information shows that although they differ in certain aspects, other things, for example, 
their staple foods are the same. It is recommended that researchers conduct further research in other 
Caribbean countries so that a full picture can be sought regarding the barriers and facilitators of T2DM 
management. The systematic review, however, also had limitations. There were no studies found which 
covered the views of healthcare providers and family/carers. It is important to have healthcare 
professionals and family/carers views as there are these are the people directly involved in the 
management of a patients’ T2DM. Whether it may be family/carers assisting with medication regime or 
healthcare professionals providing care, they all play an essential role in ensuring proper T2DM 
management.(162–167) Therefore, their views on barriers and facilitators to T2DM management is equally 
important as those from the patients. Another limitation of this study was the elimination of 11 papers 
due to no full-text being available, six of these papers were abstracts or poster presentations. These 
papers may have been beneficial to the study by adding additional patient-reported barriers and 
facilitators. Finally, the meta-aggregation method followed in the synthesis differed slightly to that 
recommended by JBI, where we included all findings irrespective of their level of credibility. We did this 
to ensure that the phenomena of interest was made clear and because the authors of the study 
described the way they qualitatively explored the phenomenon.(122) The text from the open-ended 
interviews and patients description were used to form themes which were later interpreted to identify 
the motivational factors and barriers to therapeutic lifestyle changes. Although there were no 
text/illustrations reported, quantitative calculations showed how many patients gave a particular 
response.(122) This resulted in 17 findings from one study(122) being included in the meta-aggregation 
which had no supported findings, which contributed significantly to the synthesised findings. The 
researchers did not report the review in terms of ENTREQ as the study did not meet the guidelines,  
3.6.2. Implications 
Firstly, as this systematic review is now the most recent and comprehensive review of the evidence on 
barriers and facilitators to guide healthcare practice, the moderate to high confidence in the qualitative 
results are pivotal in the successful management of T2DM patients in the Caribbean. Secondly, with 
the information provided, patients should now be able to relate to other patients and have a clearer 
understanding of what will help them manage their disease and what will not. For example, knowing 
what actions, beliefs or personal traits are classified as harmful to their health and what is beneficial. 
Thirdly, the findings will allow T2DM patients to be more effective and efficient in communicating with 
healthcare professionals to decrease non-compliance and non-adherence. It is also imperative that the 
T2DM patients are given the appropriate resources and guidance to address the barriers that they face 
and promote the facilitators, all through education. This may include high-quality T2DM management 
guidelines, interventions that can be used on patients and policies. Fourthly, the results from this 
systematic review will allow policymakers to develop evidence-based recommendations/policies which 
deals with the issues presented. Policymakers may find it useful to ensure that resources are available 
and affordable, e.g. healthy foods medicines, and there are safe environments for exercise. As well as 
develop policies to develop and provide supportive environments to T2DM patients to help motivate 
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them. Policymakers may also find focusing on educating people more and giving advice on the disease, 
appropriate diet and medicines and physical activity very useful.(168) Some other studies which were 
conducted in the United States showed that tailored advice and personal guidance are more productive 
and more consistently associated with good health outcomes and behaviour change.(169–171) Lastly, 
there were a few issues identified throughout the studies included in the review. Although all the studies 
were of high quality, the critical appraisal highlighted the common poor reporting of the influence of the 
researcher on the research amongst the studies. 
The Caribbean region is a large multi-cultural/multi-ethnic diverse area. Due to the history of 
colonisation by many nations and immigrants, multiple ethnic groups from across the world merged. 
The Caribbean people are mostly descendants from different ethnic backgrounds such as Africans, 
Europeans, Asians, Tainos and Caribs East Indians. This indicates that the region is not made up of 
one ethnicity and one culture, therefore, when healthcare professionals are planning ways to eliminate 
barriers and increase facilitators in the different countries different cultural and ethnic background 
should be taken into consideration. As the findings were Caribbean T2DM patients, their views and 
perspectives can be different from other populations such as healthcare professionals and 
family/carers. However, because healthcare professionals and family/carers are usually the ones caring 
for T2DM patients, they would be able to assist in promoting the facilitators and tackle the barriers 
identified as quickly as possible based on this evidence.  
 
3.7. Conclusion  
This was the first systematic review to explore the barriers and facilitators to T2DM management in 
people from the Caribbean. Overall, the findings showed that the barriers of T2DM management 
amongst patients in the Caribbean are sociocultural norms, demands/pressures and influences, poor 
environmental context and resources, poor support from the most immediate influences, personal 
background and circumstances which limit, influence of emotions on T2DM management, influence of 
psychological factors towards management of T2DM and the adherence to T2DM management. The 
facilitators to T2DM management amongst patients in the Caribbean are good support from the most 
immediate influences, personal background and circumstances which encourage good self-
management and general management of T2DM, positive influence of emotions, psychological factors 
and positive personal attitudes of T2DM patients towards the adherence of treatments. Further research 
is needed which explores the views and experiences of T2DM healthcare professionals and families 
and carers of people with T2DM so that a more precise picture regarding the barriers and facilitators to 
the management of T2DM in people from the Caribbean is available. 
3.7.1. Recommendation for practice 
Based on the evidence highlighted in the summary of findings (Table 9), the JBI grades of 
recommendations was used to assist in the development of the following recommendations shown in 
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Table 4. A binary system for grading the recommendations, a ‘strong’ recommendation (Grade A) or a 
‘weak’ recommendation (Grade B) was used (Table 10).(172)
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Table 9: Summary of findings 
Systematic review title: Barriers and facilitators to type 2 diabetes management in the Caribbean region: a qualitative systematic review. 
Population: Type 2 diabetes patients adults (aged 18 and above), family/carers, healthcare professionals.  
Phenomena of interest: Views, experiences, attitudes, understandings, perceptions and perspectives regarding the barriers and facilitators to type 2 diabetes 
management. 
Context: The Caribbean region.   
Synthesised findings (T2DM patients level) Type of 
research  
Dependability  Credibility ConQual 
score 
Comments 
From the participants perspective sociocultural norms, 
demands and pressures were found to impact self-
management and general care of T2DM: 
Cultural demands/pressures, traditional non-evidence based 
traditional medicines or therapies and social stigma are 
barriers to T2DM management. Evidence highlighted how 
patients continued to consume local unhealthy foods despite 
the repercussions. Shame and judgement were passed from 







level as 3 out of 5 
“yes” responses.  
Credibility: 7 out of 9 
findings were   
unequivocal.  
From the participants perspective environmental context 






High Dependability: 4 out 
of 5 “yes” responses. 
Credibility: Only 
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Physical activity/ in built environment and lack of resources 
are barriers to T2DM management. Patients did not feel safe 
in the areas in which they had to exercise and in addition, 
there was a shortage in supplies which are vital in T2DM 
management. 
unequivocal findings. 
From a patients perspective support systems were 
influential on the general management of T2DM: 
There were different types of support given to T2DM patients 
which did not help improve their management. Lack of 
support from family and friends and incorrect/ negative 
advice from family and friends are barriers to T2DM 
management. 
Positive support from family and friends and good support 
from healthcare personnel are facilitators to T2DM 
management. Religious, family and friends and health care 






High Dependability: 4 out 
of 5 “yes” responses.  
Credibility: 
Downgraded one 
level as 11 out of 13 
findings were 
unequivocal.  
From the participants perspective personal background 
and circumstances can encourage and limit good self-









level as 8 
unequivocal and 3 
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Factors such as competing priorities/ physical activity, co-
morbidities/ medical history and inadequate knowledge are 
barriers to T2DM management. 
Perceived benefits of physical activity, increased knowledge 
are facilitators to T2DM management. They were personal 
backgrounds and circumstances which positively impacted 
patients ability to manage their T2DM. 
unsupported 
findings.  
From the participants perspective emotional factors 
were found to influence patients’ actions towards 
management of T2DM : 
Emotions or the way persons felt about having the disease 
affected if and how persons managed their T2DM. Emotional 
factors influences his/her action to seek contentment and 
appropriate T2DM management assistance, resulting in 
negative results. Low mood and low motivation, fear of the 
disease/ complications and denial are barriers to T2DM 
management. It includes positive outcomes as a result of a 
person’s thinking that influences his/her action to seek 
contentment. High mood and high motivation and fear of the 










levels as 10 
unequivocal, 1 




From the participants perspective psychological factors 
were found to  influence  patients’ adherence to T2DM 
management: 
Negative and Positive attitudes and beliefs were able to 
impact weather persons obeyed or follow their T2DM 
management regimen. Negative personal attitudes is a 
negative way of thinking or feeling based on experiences, 
values and beliefs. Negative personal attitude towards 
adherence of good T2DM management is a barrier to T2DM 
management. 
Positive personal attitudes is a positive way of thinking or 
feeling based on experiences, values and beliefs. Positive 
personal attitudes towards the adherence of good T2DM 
management is a facilitator to T2DM management.  Religion 










level as 13 
unequivocal, 4 




Table 10: Grades of recommendations for practice 
Grades of recommendations 
Grade A Patients should be educated on the appropriate medicines to use for their T2DM 
management and the risks of using of non-evidence-based medicines. 
Grade A Patients with pre-existing co-morbidities or have a medical history which may 
impact or may be impacted by T2DM should be given educational resources by 
their healthcare providers. The educational resources should entail how to 
manage their co-morbidities with their T2DM. 
Grade A T2DM patients should be educated on T2DM, with special focus on the 
misconceptions (which has also lead to fear) and possible complications 
associated with the disease and different ways to deal with it.  
Grade A Long term support (physical and emotional) should be considered and provided 
by family, friends and spouses to T2DM patients. 
Grade A Educational support should be considered for family, friends and spouses who 
live with or care for T2DM patients. 
Grade A Faith based groups should consider developing supports groups for T2DM 
patients.  
Grade A Societies should be educated on T2DM with the aim of reducing the stigma 
associated with T2DM. 
Grade A Healthcare providers should consider building a rapport with their patients, to 
develop doctor-patient trust/ relationship so that patients are more likely to  
adhere to their instructions which should promote good T2DM management. 
Grade A  Governments should consider ensuring that educational resources and healthy 
food options are available to T2DM patients. 
Grade A  The Governments or the Ministries of Health should consider the accessibility 
and affordability of medicines to T2DM patients, by lowering the prices or 
making them free. 
Grade A The Governments should consider providing professional psychological help/ 
assistance to T2DM patients who are experiencing any emotional and 
psychological issues. 
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Grade A Policymakers should consider developing health promotion activities based on 
physical activity targeting T2DM patients who struggle to be physically active 
due to busy lifestyles. These activities should be tailored to be incorporated into 
their daily lives. 
Grade A Policymakers should consider implementing accessible and safe physical 
activity programs for all types of T2DM patients. 
Grade A Policymakers should consider re-introducing healthy diet plans or healthy food 
options to T2DM patients using more of their native food. 
 
3.7.2. Recommendation for research  
Throughout the characteristics of data extraction, it was evident that there was poor reporting of the 
methodology in more than half of the studies. Some of the characteristics were not reported, and others 
were not reported in detail. It is recommended that researchers ensure that their methodology is 
thorough and included all the necessary information. Although a few qualitative studies were identified, 
there should be more qualitative studies on T2DM management conducted in more Caribbean countries 
so that a broader range of islands can be included in the summary of evidence. Future qualitative 
studies should also include healthcare professionals and carers perspectives since this systematic 
review was only able to synthesise findings from patients’ perspective. Hopefully, the experiences, 
views and perspectives from other individuals may identify more barriers and facilitators that were not 




Chapter 4: Discussion 
4.1. Summary of the study 
The research within this thesis was in response to the documented cases, complications and death 
from T2DM in the Caribbean region. The findings from this research can assist with future study 
designs, developmental plans, and strategies to combat these issues. The research conducted in this 
thesis used an exploratory formative method to highlight and raise awareness of some of the disparities 
impacting T2DM management in the Caribbean region. It provided answers to the following questions 
‘do healthcare practitioners have the appropriate and best quality guidance needed to assist with T2DM 
management?’ and ‘what are the factors hindering or promoting proper T2DM management?’. 
The results indicated that the overall content and quality of the Caribbean T2DM guideline published in 
2006 was poor when compared to more recent international guidelines. Significant issues were 
identified in the current Caribbean guideline, which has resulted in the need for improvement. The study 
identified that patients in the Caribbean region have multiple barriers and facilitators, limiting and 
promoting effective management of their T2DM. The results suggested that the issues identified (poor 
quality guideline and barriers) were predominantly responsible for poor T2DM management. The 
information provided in this research should assist various governments, health officials and other 
existing health organisations in the fight against T2DM. 
Although the proposal of the two studies did not include any theories or framework, this thesis was able 
to draw on different theories and frameworks such as the framework for guideline dissemination and 
implementation and theoretical domain framework of behaviour change. These frameworks allowed the 
researchers to form a link between the barriers and facilitators to T2DM management and the quality 
of T2DM management guideline in the Caribbean, and provide information to improve the effective 
dissemination and implementation strategies to ensure successful T2DM management. The domains 
identified (social influences, environmental context and resources, beliefs about consequences, 
emotions, motivation and goals, behavioural regulations and knowledge) provide a comprehensive 
framework to encourage the consideration of good coverage of influencers to behavioural change and, 
as a result, improves the intervention implementation.(80,81)  
 
4.2. Discussion of findings 
4.2.1. Guideline appraisal  
It is unknown whether healthcare professionals (clinicians) in all the Caribbean use the current 
guideline. However, suppose there are countries that still use it. In that care, this may play a significant 
role in the management of T2DM as there are profound health implications associated with the poor 
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quality of the Caribbean T2DM guideline. The inadequacies of the Caribbean T2DM guideline may play 
a significant role in the management of T2DM and, by extension, high mortality and morbidity rate. It is 
known that one significant limitation of mediocre quality clinical guidelines is incorrect 
recommendations. This is possible due to scientific evidence provided being misleading, lacking (of 
information or clarity) or misinterpreted. Some recommendations may be influenced due to the opinions 
of the guideline development group.(86)The Caribbean T2DM guideline consisted of a policy 
development group that consisted of different healthcare professionals from various countries and 
different areas of expertise. There was a lack of T2DM specialists in the guideline development group, 
which may have led to unsuitable recommendations. Persons were also from different countries within 
the Caribbean, and though the culture of the countries may be the same, other things may differ, such 
as their economic status. As a result of minor differences among the islands, persons from the guideline 
development group could have made recommendations reflecting their experience and country’s 
economic status. Another disadvantage of the poor quality guidelines is their inflexibility.(86) These 
guidelines do not consider patients with unique circumstances and personal histories, which hinders 
healthcare professionals from adapting to the patient’s needs, thus resulting in unsafe practices.(86)  
Studies have shown that the quality of clinical guidelines is usually mediocre due to the procedures 
followed in its development or lack thereof.(86,173,174) In this case, the Caribbean T2DM guideline did not 
follow a robust development procedure. For example, it did not include a systematic process to gather 
and synthesise evidence or methods to formulate the recommendations (e.g. GRADE) and update 
them. This had a major impact on the guideline quality as there was no scientific evidence or data to 
justify the recommendations made. The lack of this information implies that the healthcare professionals 
in the Caribbean are not receiving the appropriate guidance needed to ensure that they provide 
adequate care to their patients. This may have also led to a lack of trust from the healthcare 
professionals. It is known that the implementation of guideline recommendations by healthcare 
providers continue to be challenging.(86,175) Some known reasons associated with why healthcare 
practitioners may not adhere to guidelines are: lack of awareness and familiarity of its content; not 
agreeing with it due to lack of interpretation or evidence; lack of self-efficacy due to insufficient training 
or experience; patient factors such as their awareness and involvement; and lack of consistency 
amongst guidelines.(107,175,176)  This research highlighted that not one aspect of T2DM management was 
included in all ten guidelines, which proves a lack of consistency among guidelines.  
In some Caribbean countries, e.g. Grenada, healthcare professionals do not use the Caribbean T2DM 
guideline. As a result, they follow other high-quality guidelines, e.g. ADA, and the others may or may 
not use guidance at all. In addition, some guidelines also lack advice and recommendations to tackle 
barriers faced by the healthcare providers, e.g. lack of clinical equipment and medications, lack of 
human resource in polyclinics and lack of coordinated team approach.(89) As most Caribbean countries 
fall in the LMICs, we can assume that most of them struggle with a lack of T2DM medical resources, 
especially medications that patients need but cannot afford. It is imperative that healthcare 
professionals are fully equipped with the necessary tools needed to do their jobs. They would not be 
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able to follow the recommendations of a guideline if they do not have the tools required to do so. This 
is likely to lead to poor quality of care of T2DM patients.  
As we know, T2DM management does not only entail achieving blood glucose control targets. It also 
includes preventing and/or reducing the risk of the development of complications.(177) Most guidelines, 
including the one produced by the Caribbean, included these aspects of T2DM management. However, 
it must be highlighted that this guideline was last updated in 2006 and does not include new T2DM 
management technological advances (stick-free glucose testing, insulin pumps and pens) and new 
ways to improve patient care.(178) This can only mean that T2DM patients are not receiving the best 
resources available and best care options to manage their diabetes.  
4.2.2. Barriers and facilitators of T2DM management 
The barriers and facilitators of T2DM management in the Caribbean include sociocultural norms 
demands and pressures that impact self-management and general care of T2DM; environment context 
and resources used in management impact the management of T2DM; support systems influence on 
the general management of T2DM; personal background and circumstances that encourage and limit 
good self-management and general management of T2DM; emotional factors that influence patients’ 
actions towards management of T2DM; and psychological factors and their influence on patients’ 
adherence to T2DM management. There were more barriers than facilitators faced by Caribbean T2DM 
patients, which shows that there are more factors to overcome or eliminate to ensure proper T2DM 
management. These barriers have negatively impacted the quality of care and quality of life of T2DM 
patients. Factors such as cultural beliefs, knowledge, medical history/comorbidities, lack of resources 
(money), emotional state(mood, stress, fear) and support, prevents patients from accessing the 
appropriate care as well as adhering to and practising proper management (including self-
management). On the other hand, the facilitators will do the opposite but can also inform and help 
promote positive actions that lead to positive outcomes, good T2DM management. The evidence has 
shown that these (beliefs, knowledge, psychological state, support from family/friends and healthcare 
professionals) are the main factors assisting in or resulting in proper T2DM management. These 
facilitators should be promoted and, in some cases, they should be improved on for a better outcome. 
These results were similar to two recent systematic reviews conducted in Latin America and the 
Caribbean, and Africa.(76,179) There were some additional barriers (such as insurance coverage, weather 
conditions and gender role(76), sexual function, self-management practices(foot care), employment 
problems(179) and facilitators (such as peer support and mass media providing educational messages) 
that were not identified in this study. This may have been due to the additional countries (Latin America) 
included in the research. Most of these countries are located on a continent with a different social, 
economic, and cultural structure to that of the Caribbean. This particular study was also able to 
summarise healthcare professionals perspectives, most likely because they included Latin America and 
was able to identify more studies.(76) Some interesting findings were that knowledge was both a barrier 
and facilitator of proper T2DM management. Insufficient knowledge is a barrier as it led to 
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miscommunication and poor management of side effects and complications. Updated training being 
provided to health providers was a facilitator to proper T2DM management.(76) They also highlighted 
barriers associated with gender roles adopted by men and women. For example, men are associated 
with high alcohol consumption and prioritising their work which impeded T2DM care, while women 
prioritised taking care of others in the family. Although this study did not identify these barriers 
associated with gender roles, it highlighted that male patients were more likely to be afraid of doctors, 
making them more vulnerable to T2DM complications. The study conducted in Africa highlighted 
support from family, significant others and religious relationships both negative and positive effects on 
T2DM management which was also identified in this study.(179) However, this study did not highlight the 
effects of T2DM on sexual relationships. This may have been due to the sensitive nature of the topic. 
Persons may not have been comfortable speaking about reduced sexual function. No aspect of foot 
care was not mentioned by participants in the Caribbean but was mentioned by the participants in 
Africa. It was made clear that they had not sought specialist medical care, while some attempted to 
care for it themselves with homemade remedies. Caribbean participants may not have mentioned foot 
care as it may not be a priority in their T2DM management practices. Employment problems were 
highlighted in the study from Africa but not from the Caribbean. T2DM resulted in being unwell and 
unable to work or missing work due to hospital visits, which resulted in unemployment ultimately leading 
to no source of funds and the inability to afford the necessary medicines to manage T2DM. (179)  Another 
interesting finding was that environmental context and resources (within the health system) was both a 
barrier and facilitator to successful T2DM management in both studies. (76,179) In the Latin America and 
Caribbean study, the lack of health insurance/health care access, lack of resources (human and 
physical) and organisational weakness were identified as barriers. However, some of these were also 
seen as facilitators; good insurance coverage and health access, strong organisational structure, 
multidisciplinary teams and sufficient human resources.(76) In Africa, it was found that the attitudes of 
the healthcare workers and service delivery both assisted and prevented successful T2DM 
management.(179) The healthcare professionals in the Latin America and Caribbean study also 
highlighted and agreed on the barriers and facilitators perceived by patients. An example was that faith 
in God was a barrier and facilitator, this was also identified in this systematic review.(76) 
The barriers and facilitators to T2DM management identified in this study can and should influence the 
evidence and recommendations provided when developing a high-quality Caribbean T2DM 
guideline.(115) It will allow the guideline development group to create recommendations that address the 
barriers specifically or consider them when developing recommendations. It will also allow them to 
provide the evidence to match the circumstances being faced in the Caribbean. For example, the high 
prices of medication and foods should be taken into consideration when developing guidelines. 
4.2.3. Low adoption of T2DM guideline as a potential barrier to T2DM  
Although the systematic review did not find any studies with healthcare professionals’ perspectives, a 
study has highlighted that outdated or lacking guidelines can be barriers to T2DM management 
experienced by healthcare providers.(180) When assessing the quality of T2DM clinical guidelines, 
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previous research has recognised that poor quality guidelines were mainly seen in Latin America and 
Caribbean countries guidelines. The author also highlighted the constant efforts needed to produce and 
update high-quality clinical guidelines to improve T2DM management.(114) Another study also indicated 
there were some issues concerning the Caribbean T2DM guideline. One of the issues was that the 
clinical guideline was not tailored to the circumstances or issues faced by healthcare providers.(89) 
Although the systematic review was unable to identify the barriers experienced by healthcare 
professionals, from the study conducted in Latin America and the Caribbean, insufficient professional 
knowledge to manage side effects and communicate with patients and lack of physical resources were 
barriers experienced by healthcare professionals.(76) The Caribbean T2DM guideline provided limited 
information on managing side effects and complications and showed no evidence of considering lack 
of resources. Based on existing evidence which proves that poor guidelines lead to poor quality 
healthcare and poor health outcomes, the current Caribbean T2DM guideline may also be a barrier to 
T2DM management in the Caribbean. Although this was not stated as a barrier by the patients, it could 
be a barrier for healthcare professionals since most guidelines are targeted to them.  
4.2.4. Systematic review and guideline appraisal  
The results from the systematic review can be used to inform the improvement of the current T2DM 
Caribbean guideline or the adaptation of other guidelines. For example, the systematic review 
highlighted a shortage of supplies vital to T2DM management, consumption of local unhealthy foods, 
the negative impact of emotional and phycological factors and use of non-evidence-based traditional 
medicines as barriers to T2DM management. Firstly, funding should be arranged and dedicated to 
future researchers for guideline development or adaptation, as well as guideline developers can ensure 
that the guideline for the Caribbean includes supplies that are readily available to the population or 
provide an alternative. Secondly, they may include a section for unhealthy local foods to make clear the 
foods that should not be consumed. The Caribbean guideline currently contains an overall grouping of 
foods (cereals, ground provisions, fruits and veg, fats and oils, legumes and nuts) and recommends if 
its’ to be eaten regularly or in moderation. Thirdly, as stress was a significant barrier to T2DM 
management, a section should be included with materials on how to cope with stress and other 
psychological factors relating to T2DM or as a result of T2DM. Lastly, alongside the evidence-based 
medicines/therapies, the guideline can exclusively state the different non-evidence-based traditional 
medicines (common in the Caribbean, e.g. bush teas) which are not to be used.  
There were results from the guideline appraisal, which can be linked to the barriers and facilitators 
identified in the systematic review. The guideline appraisal showed that the guideline is inadequate in 
certain aspects of the evidence provided. This may have resulted in insufficient education/knowledge 
relating to T2DM management, which may have ultimately led to poor self-management and 
limited/inadequate support received by T2DM patients. From another perspective, due to inadequate 
knowledge persons (highlighted in the systematic review), persons may not be aware of the guideline 
and its importance to ensure successful  T2DM management. 
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The results from the two empirical studies conducted within this thesis should now provide evidence to 
assist with improving of T2DM management in particular dissemination and implementation. They will 
help address and improve the quality of care received by T2DM patients and their health outcome. It is 
essential that this information reaches the appropriate people to ensure that a change is made. As 
knowledge of T2DM and its management was such a significant barrier, it is vital that the evidence 
provided by this study is shared and received by the target population so that they can make evidence-
based decisions. The following section will address the best ways to disseminate the results most 
effectively. 
 
4.3. Strengths and limitations 
4.3.1. Strengths 
The content of this thesis has both strengths and limitations. To start, the strengths of the research 
conducted within the thesis will add to its significance in the literature. One strength was the coverage 
of countries included, so that the findings can be generalisable for the entire Caribbean rather than one 
or a few of the countries. Secondly, this thesis used two different types of methodology to produce 
evidence. One was a systematic review, and the other was a critical appraisal. They both entailed 
systematic processes to be followed, which increased the results’ reliability, quality, and 
trustworthiness. Thirdly, two paid external research assistants were involved with the two included 
studies in this thesis. One researcher assisted in the systematic review analysis and the other assisted 
with the critical appraisal. Lastly, this research project adds significant evidence to the literature. Thus 
far, no study has appraised the Caribbean’s T2DM guideline and no study has summarised the barriers 
and facilitators of T2DM in the Caribbean region. 
4.3.2. Limitations 
There were a few limitations identified during this research. These should be used to develop future 
studies better or used to address knowledge gaps. Firstly, the systematic review did not include barriers 
and facilitators of T2DM healthcare professionals and family/carers. This was an important factor of the 
research as their views, thoughts, and perceptions of T2DM management would have been different. 
As a result, their barriers and facilitators were not identified, and no recommendations were made. 
Secondly, some of the findings in the systematic review had a low or moderate ConQual score, which 
highlights the decreased credibility and dependability of some of the evidence. Thirdly, there was 
insufficient time to conduct a primary qualitative to explore the thoughts, views and experiences of the 
current Caribbean T2DM management guideline and explore the thoughts, views and experiences of 
healthcare professionals and family and carers on T2DM management. Finally, there is also a lack of 
previous research studies conducted within the Caribbean on the topic, and limited access to data. 
There was minimal background data on T2DM in the Caribbean, therefore a thorough assessment could 
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not be made. Also, some papers did not have a full-text version, especially for the systematic review. 
This may have led to new findings or more findings that would have supported and strengthened the 
results.  
 
4.4. Implications for practice in research   
The findings of this thesis can allow for informed decisions to be made on many levels such as patient, 
family, carers, healthcare professionals, Government (ministries of health), health organisations, 
policymakers, and research levels. However, dissemination of this research is needed to raise 
awareness in patients with T2DM, their family and carers and health care professionals; the 
dissemination strategy of this research can be found in the following section. This research will inform 
patients, family and carers on the common disparities associated with T2DM, as some of the issues 
identified here may not be perceived as such to them. As a result of this research and the frameworks 
highlighted, they are now aware and can make lifestyle changes and seek guidance and help where 
necessary to ensure that their T2DM is successfully managed. Healthcare professionals can use the 
experiences and views of patients also to help them make informed decisions which can lead to better 
medical practices. This study will allow healthcare professionals to better understand their patients and 
their needs, particularly the areas they struggle with the most, e.g. adherence to medications. As it is 
now clear that one of the reasons that patients struggle with adherence to medication is their cultural 
beliefs, healthcare professionals should consider educating them more on the correct medicines and 
why what they are used to taking is bad and would not work effectively. The evidence from this study 
will also educate healthcare professionals on the issues of the Caribbean T2DM guidelines and what 
should be expected from a high-quality guideline. They should also advocate for the current T2DM 
management guideline to be updated to ensure they are adequately guided with evidence-based 
recommendations. 
Government (Ministries of Health), health organisations, policymakers and health promotion strategists 
can now work together to achieve the same aim, which is to ensure proper T2DM management. With 
the information provided from this thesis, they can develop effective T2DM management programs by 
using the barriers and facilitators to guide them. An example can be to implement group support 
programmes for T2DM patients, including healthcare professionals and family and carers. Here they 
will be able to freely talk about the pros and cons of their T2DM and be given advice on ways to deal 
with the issues they may be facing or even physical help if needed. The Government should consider 
developing educational programmes for patients, family and carers and healthcare professionals. 
These educational programmes should address all the disparities identified in this research and ways 
to overcome them. The educational programmes should also consist of essential information on the 
disease, for example, what is T2DM, the best ways to manage T2DM (lifestyle measures and 
medicines) and the complications associated with T2DM. On an environmental level, the Government 
can raise awareness of health-promoting infrastructures. They can encourage T2DM patients to use 
parks (some may include weight machines) as well as raise awareness of the designated safe areas 
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for exercising. Policymakers and health promotion strategists can use the evidence to develop public 
health policies and health promotion strategies targeting good T2DM management. One study 
emphasised that successful T2DM management requires a focus on public policies to strengthen 
healthcare access and resources.(76) Public policies will ensure that all the resources needed to ensure 
that patients receive the appropriate care are available and accessible, e.g. hospital visits (check-ups), 
medicines and qualified nutritionists. The health promotion strategy should focus on healthy lifestyle 
activities. This may include discounts on healthy foods or implementing 5-a-day similar to the United 
Kingdom. It may also include the development of community exercising groups or sports groups, e.g. 
netball or football. 
As the current Caribbean T2DM management guideline was of poor quality, further research should be 
conducted to provide more recent evidence to assist in updating it. This should be the same for 
guidelines from Australia, IDF, IDF global, New Zealand, United States and United States and Europe. 
After the guidelines have been updated, future researchers should also assess the quality again using 
the AGEE II tool. The results can then be compared to the results of this study, and changes which 
highlights improvements or lack thereof can be identified. Once the issues raised from this study are 
addressed, the guidelines should be of good quality and ready to be used by healthcare professionals, 
T2DM patients, family, and carers. From this thesis and previous research, it has been deducted that 
poor quality guidelines can ultimately lead to poor health outcomes of T2DM patients. Therefore, future 
researchers can also determine if there is a significant association between the quality of the Caribbean 
T2DM guideline and the poor health outcomes of T2DM patients in the Caribbean region, including both 
healthcare professionals and T2DM patients as the study population. The results may intensify the 
findings from this research as well as bring more urgency to the T2DM epidemic in the Caribbean. It is 
recommended that further qualitative studies on barriers and facilitators to T2DM management in the 
Caribbean should be conducted as the certainty of some findings were low. Also, qualitative studies 
should be conducted to identify the barriers and facilitators of T2DM management faced by healthcare 
professionals and family/carers as no studies which explored their views were identified. 
 
4.5. Dissemination of the results to the target population  
It is important that the results from this research are used to inform its target population by using the 
most appropriate means. A persuasive communication matrix and knowledge translation were used to 
guide the dissemination of the results of this research.(181) Persuasive communication is described as 
“Who says what in which channel to whom with what effect”. Wilson also focused on McGuire’s five key 
attributes: persuasive communication, source, channel, message, audience and setting. Researchers 
commonly use this to promote and translate the findings of their studies.(182,183) 
The appraisal compared the content and quality of ten T2DM management guidelines, including the 
Caribbean guideline. The results and recommendations from this study should and would be received 
mainly by the ten countries included in the research, as well as government and health organisations 
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that focus on T2DM management guidelines. The target audience includes clinical guideline 
development group (public health experts (including policymakers), ministries of health, healthcare 
practitioners), T2DM patients and diabetes organisations. The channels used to distribute the results 
will include electronic communication channels (journal publications, emails and social media), written 
communication (letters), and personal communication (presentations).(183,184) 
The results and recommendations from the systematic review, which highlighted the barriers and 
facilitators to T2DM management in the Caribbean, would be available to the Caribbean countries, their 
respective Governments and any other country or organisation that require it. The target audience 
includes T2DM patients, family/carers, healthcare practitioners, public health experts (including 
policymakers), Government (including Ministries of Health), and diabetes organisations. The channels 
used to distribute the results will include electronic communication channels (journal publications, 
emails and social media), written communication (letters), and personal communication (presentations). 
To ensure the implementation of recommendations/ targeted activities, the involved parties should 
ensure that various tasks are completed. They should assess the country’s politics to ensure that all 
interests align and that support would be given to the specific activities. Secondly, they should ensure 
it is well organised and funded so that resources required by various projects will be available. Lastly, 
there should be promotional activities to raise awareness throughout the country. Once the 
recommendations (including various policies and programs) have been implemented, they should be 
evaluated, and feedback should be given on their impact thus far.(182,185) 
 
4.6. Conclusion  
It can be concluded that over the years, T2DM continues to have a profound negative impact on the 
people in the Caribbean region. T2DM is one of the most significant public health challenges in the 
Caribbean region in this twenty-first century. Thus far, there is very minimal research available to assist 
the Caribbean region in tackling the T2DM epidemic. This research highlighted some of the disparities 
affecting T2DM management in the Caribbean, such as poor quality T2DM management guideline and 
patient-perceived barriers.  
The Caribbean clinical guideline for managing T2DM was found to contain a high level of content 
regarding relevant topics but was of insufficient quality to be used in clinical practice. Therefore, SIGN 
T2DM management guideline should be adapted (make changes to ensure applicability in the 
Caribbean Islands based on the evidence provided from this study) and used for the clinical 
management of T2DM within the Caribbean. The SIGN guideline was identified within this study as 
high-quality, which scored over 90% in all domains. As a result, it is the most reliable resource and 
maybe be easier to adapt. Patients in the Caribbean have multiple barriers and facilitators which limit 
and promote proper management of their T2DM. Further qualitative studies on barriers and facilitators 
to T2DM management in the Caribbean which target healthcare professionals and families/carers must 
be conducted.  
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Identifying the barriers and facilitators to T2DM management in the Caribbean and the quality of the 
Caribbean T2DM management guideline will assist policymakers, patients, healthcare professionals, 
carers, family and friends to develop effective T2DM management programs to ensure the appropriate 
T2DM management. In addition to the originality of the work presented in this thesis, the knowledge 
gaps addressed can be used to make a significant impact on T2DM management in the Caribbean and 
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Appendix II: Domain calculations for guideline appraisal   
Appraiser 1- Amy  
Appraiser 2- Gowsi 
 
Country-specific (CHRC/PAHO) (73)  
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 7 1 6 14 
Appraiser 2 7 1 5 13 
Total  14 2 11 27 
 
27-6/42-6* 100= 58.33% 
 
Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 7 1 7 15 
Appraiser 2 6 1 7 14 




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
1 1 1 1 3 1 1 1 10 
Appraiser 
2 
1 1 1 1 2 1 1 1 9 





Domain 4: Clarity of Presentation 
 Item 15 Item 16 Item 17 Total 
Appraiser 1 6 7 1 14 
Appraiser 2 6 6 1 13 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 1 3 2 7 13 
Appraiser 2 1 4 2 6 13 
Total 2 7 4 13 26 
 
26-8/56-8*100= 37.5% 
Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 1 7 8 
Appraiser 2 1 7 8 




 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 3 No 
Appraiser 2 3 No 
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International Diabetes Federation (IDF) (46) 
 
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 5 5 5 15 
Appraiser 2 5 5 5 15 




Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 4 2 5 11 
Appraiser 2 5 3 6 14 




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
1 1 2 1 5 5 2 3 20 
Appraiser 
2 
1 1 2 1 5 6 4 5 25 




Domain 4: Clarity of Presentation 
 Item 15 Item 16 Item 17 Total 
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Appraiser 1 6 7 7 20 
Appraiser 2 6 7 7 20 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 4 5 4 7 20 
Appraiser 2 5 5 2 6 18 
Total 9 10 6 13 38 
 
38-8/56-8*100= 62.5% 
Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 2 3 5 
Appraiser 2 2 2 4 




 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 4 Yes, with modification 




International Diabetes Federation (IDF) (13) 
 
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 7 7 7 21 
Appraiser 2 7 7 7 21 




Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 5 2 7 14 
Appraiser 2 4 3 7 14 




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
2 3 3 3 1 6 1 1 20 
Appraiser 
2 
2 3 2 2 1 6 1 1 18 




Domain 4: Clarity of Presentation 
 Item 15 Item 16 Item 17 Total 
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Appraiser 1 6 7 7 20 
Appraiser 2 6 7 7 20 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 2 3 1 7 13 
Appraiser 2 2 2 1 7 12 
Total 4 5 2 14 25 
 
25-8/56-8*100= 35.42% 
Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 1 2 3 
Appraiser 2 1 1 2 




 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 5 Yes, with modifications 





American Diabetes Association (ADA) and European Association for the Study of Diabetes 
(EASD) (86) 
 
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 6 2 6 14 
Appraiser 2 7 3 6 16 
Total  13 5 12 30 
 
30-6/42-6 * 100 = 66.67% 
 
Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 5 5 2 12 
Appraiser 2 5 4 3 12 




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
7 1 1 2 7 5 1 1 25 
Appraiser 
2 
7 1 1 2 6 4 1 1 23 
Total 14 2 2 4 13 9 2 2 48 
 
48-16/112-16*100=  33.33% 
 
Domain 4: Clarity of Presentation 
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 Item 15 Item 16 Item 17 Total 
Appraiser 1 6 6 7 19 
Appraiser 2 7 6 7 20 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 2 4 2 7 15 
Appraiser 2 2 5 2 7 16 




Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 4 4 8 
Appraiser 2 4 3 7 





 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 3 No 




Country-specific (RACGP) (87) 
 
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 2 2 2 6 
Appraiser 2 3 3 3 9 




Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 3 2 3 8 
Appraiser 2 4 3 4 11 




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
1 2 4 2 6 5 2 2 24 
Appraiser 
2 
1 2 3 3 6 6 3 2 26 




Domain 4: Clarity of Presentation 
 Item 15 Item 16 Item 17 Total 
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Appraiser 1 7 7 7 21 
Appraiser 2 7 7 7 21 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 4 4 3 6 17 
Appraiser 2 5 5 4 5 19 




Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 4 1 5 
Appraiser 2 4 1 5 




 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 3 Yes, with modifications 





Country-specific (Diabetes Canada/CDA) (88) 
 
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 7 6 7 20 
Appraiser 2 7 6 7 20 




Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 7 6 7 20 
Appraiser 2 7 6 7 20 




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
4 6 7 6 7 7 4 6 47 
Appraiser 
2 
5 6 7 7 7 7 6 6 51 




Domain 4: Clarity of Presentation 
 Item 15 Item 16 Item 17 Total 
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Appraiser 1 7 7 7 21 
Appraiser 2 7 7 7 21 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 5 6 2 7 20 
Appraiser 2 7 7 2 7 23 
Total 12 13 4 14 43 
 
43-8/56-8*100= 72.92% 
Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 4 6 10 
Appraiser 2 5 6 11 




 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 5 Yes 





Country-specific (NZGD) (89) 
 
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 2 2 2 6 
Appraiser 2 3 3 3 9 




Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 5 2 3 10 
Appraiser 2 5 2 4 11  




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
1 1 1 2 3 5 1 1 15 
Appraiser 
2 
1 1 1 2 4 5 1 1 16 




Domain 4: Clarity of Presentation 
 Item 15 Item 16 Item 17 Total 
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Appraiser 1 5 6 3 14 
Appraiser 2 4 6 3 13 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 2 3 1 6 12 
Appraiser 2 2 3 1 5 11 
Total 4 6 2 11 23 
 
23-8/56-8*100= 31.25% 
Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 4 1 5 
Appraiser 2 4 1 5 




 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 2 No 






Country-specific (ADA) (90) 
 
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 6 3 7 16 
Appraiser 2 5 3 7 15 
Total  11 6 14 31 
 
31-6/42-6*100= 69.44%   
 
Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 4 3 7 14 
Appraiser 2 5 3 7 15 




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
4 1 3 3 7 7 2 4 31 
Appraiser 
2 
5 1 4 3 7 7 3 4 34 




Domain 4: Clarity of Presentation 
 Item 15 Item 16 Item 17 Total 
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Appraiser 1 7 7 7 21 
Appraiser 2 7 7 7 21 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 4 3 5 6 18 
Appraiser 2 5 5 6 5 21 
Total 9 8 11 11 39 
 
39-8/56-8*100= 64.58% 
Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 4 3 7 
Appraiser 2 4 4 8 




 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 5 Yes, with modification 




Country-specific (NICE) (47) 
 
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 7 7 7 21 
Appraiser 2 7 7 7 21 




Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 6 7 7 20 
Appraiser 2 7 5 7 19 




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
7 6 7 7 7 7 7 7 55 
Appraiser 
2 
7 7 7 7 7 7 7 7 56 




Domain 4: Clarity of Presentation 
 Item 15 Item 16 Item 17 Total 
 124 
Appraiser 1 7 7 6 20 
Appraiser 2 7 7 7 21 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 5 6 7 7 25 
Appraiser 2 6 7 7 7 27 
Total 11 13 14 14 52 
 
52-8/56-8*100= 91.67% 
Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 4 5 9 
Appraiser 2 4 7 11 




 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 7 Yes 





Country-specific (SIGN) (91,92) 
 
Domain 1: Scope and Purpose 
 Item 1 Item 2 Item 3 Total 
Appraiser 1 7 7 7 21 
Appraiser 2 7 7 7 21 




Domain 2: Stakeholder Involvement 
 Item 4 Item 5 Item 6 Total 
Appraiser 1 7 7 7 21 
Appraiser 2 7 7 7 21 




Domain 3: Rigour of Development 
 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14 Total 
Appraiser 
1 
5 5 5 7 7 7 6 5 47 
Appraiser 
2 
7 7 7 7 7 7 7 7 56 




Domain 4: Clarity of Presentation 
 Item 15 Item 16 Item 17 Total 
 126 
Appraiser 1 7 7 6 20 
Appraiser 2 7 7 7 21 




Domain 5: Applicability 
 Item 18  Item 19  Item 20 Item 21 Total 
Appraiser 1 5 6 7 6 24 
Appraiser 2 7 7 7 7 28 
Total 12 13 14 13 52 
 
52-8/56-8*100= 91.67% 
Domain 6: Editorial Independence 
 Item 22 Item 23 Total 
Appraiser 1 6 6 12 
Appraiser 2 7 7 14 




 Rate overall quality of this 
guideline 
I would recommend this 
guideline for use 
Appraiser 1 6 Yes 











MEDLINE (1946- 11th March, 2020)  
1. exp diabetes mellitus, type 2/ 
2. exp diabetes complications/ 
3. (MODY or NIDDM or T2DM).tw,ot. 
4. ((typ? 2 or typ? II or typ?2 or typ?II) adj diabet$).tw,ot. 
5. 1 or 2 or 3 or 4 
6. (barrier* or impediment* or challenge* or hindrance* or obstacle* or hurdle* or 
obstruction* or deterrent* or facilitator*).mp.  
7. exp qualitative research/  
8. exp interview/  
9. exp focus groups/  
10. exp cross-sectional studies/  
11. exp surveys and questionnaires/  
12. (qualitative or interview* or focus group* or cross-sectional or cross sectional or 
survey*).mp.  
13. 6 or 7 or 8 or 9 or 10 or 11 or 12 
14. exp Caribbean Region/  
15. (Trinidad and Tobago).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, floating sub-heading word, keyword heading word, 
protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier, synonyms] 
16. exp Antigua and Barbuda/ 
17. exp Barbados/ 
18. exp Martinique/ 
19. exp Dominican Republic/  
20. exp Haiti/ 
21. exp Jamaica/ 
22. exp Puerto Rico/ 
23. exp Cuba/ 
24. exp Bahamas/  
25. exp Dominica/ 
26. exp Saint Lucia/ 
27. exp Grenada/ 
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28. exp Guadeloupe/ 
29. exp Curacao/ 
30. exp Aruba/ 
31. exp Netherlands Antilles/ 
32. exp United States Virgin Islands/ 
33. exp British Virgin Islands/ 
34. exp Saint Kitts and Nevis/ 
35. exp Sint Maarten/ 
36. exp West Indies/  
37. exp Saint Vincent and the Grenadines/ 
38. ((Caribbean) or (Trinidad) or (Tobago) or (Antigua) or (Barbuda) or (Barbados) or (Martinique) 
or (Dominican Republic) or (Haiti) or (Hispaniola) or (Jamaica) or (Puerto Rico) or (Cuba) or 
(Bahamas) or (Dominica) or (Saint Lucia) or (Grenada) or (Guadeloupe) or (Curacao) or 
(Bonaire) or (Aruba) or (Saba) or (Saint Eustatius) or (Virgin Islands) or (Tortola) or (Virgin 
Gorda) or (Jost Van Dyke) or (Anegada) or (Saint Croix) or (Saint Thomas) or (Saint John) or 
(Saint Kitts) or (Nevis) or (Saint Christopher) or (Sombrero) or (Saint Martin) or (Sint Maarten) 
or (West Indies) or (Saint Vincent) or (Grenadines) or (Eastern Caribbean) or (Greater Antilles) 
or (Lesser Antilles) or (Leeward Islands) or (Windward Islands) or (Caribbean Islands) or 
(Cayman Islands) or (Montserrat) or (Turks and Caicos Islands) or (Anguilla) or (Saint 
Barthelemy)).mp.  
39. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 
28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 
40. 5 and 13 and 39  
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Embase (1947- 11th March, 2020) 
1. type 2 diabetes.mp. or non insulin dependent diabetes mellitus/  
2. diabetes complications.mp. or diabetic complications/ 
3. (MODY or NIDDM or T2DM).mp. [mp=title abstract, heading word, drug trade name, original 
title, device manufacturer, drug manufacturer, device trade name, key word, floating 
subheading word, candidate term word] 
4. (MODY or NIDDM or T2DM).tw,ot. 
5. ((typ? 2 or typ? II or typ?2 or typ?II) adj diabet$).tw,ot. 
6. 1 or 2 or 3 or 4 or 5 
7. (barrier* or impediment* or challenge* or hindrance* or obstacle* or hurdle* or 
obstruction* or deterrent* or facilitator*).mp.  
8. qualitative research.mp. or qualitative research/ 
9. interview.mp. or interview/  
10. focus groups.mp. or information processing/ 
11. cross-sectional studies.mp. or cross-sectional study/ 
12. (surveys and questionnaires).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword, floating subheading word, candidate term word]   
13. (qualitative or interview* or focus group* or cross-sectional or cross sectional or 
survey*).mp.  
14. 7 or 8 or 9 or 10 or 11 or 12 or 13 
15. Caribbean Region.mp. or Caribbean/ 
16. (Trinidad and Tobago).mp. [mp=title, abstract, heading word, drug trade name, 
original title, device manufacture, drug manufacturer, device trade name, 
keyword, floating subheading word, candidate term word] 
17. (Antigua and Barbuda).mp. [mp=title, abstract, heading word, drug trade name, 
original title, device manufacture, drug manufacturer, device trade name, 
keyword, floating subheading word, candidate term word] 
18. Barbados.mp. or Barbados/ 
19. Martinique.mp. or Martinique/ 
20. Dominican Republic.mp. or Dominican Republic/  
21. Haiti.mp. or Haiti/ 
22. Jamaica.mp. or Jamaica/ 
23. Puerto Rico.mp. or Puerto Rico/ 
24. Cuba.mp. or Cuba/ 
25. Bahamas.mp. or Bahamas/  
26. “Dominican (Dominica)”/ or Dominica.mp. or Dominica/ 
27. Saint Lucia.mp. or Saint Lucia/ 
28. Grenada.mp. or Grenada/ 
29. Guadeloupe.mp. or Guadeloupe/ 
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30. Curacao.mp. or Curacao/ 
31. Aruba.mp. or Aruba/ 
32. Netherlands Antilles.mp. or Netherlands Antilles/ 
33. United States Virgin Islands.mp. or “Virgin Islands (U.S.)”/ 
34. British Virgin Islands.mp. or Virgin Islands (British)”/ 
35. (Saint Kitts and Nevis).mp. [mp=title, abstract, heading word, drug trade name, 
original title, device manufacturer, drug manufacturer, device trade name, 
keyword, floating subheading word, candidate term word] 
36. Sint Maarten.mp. or Saint Martin (Dutch)”/ 
37. West Indies.mp. or Caribbean Islands/ 
38. (Saint Vincent and the Grenadines).mp. [mp=title, abstract, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword, floating subheading word, candidate term word] 
39. ((Caribbean) or (Trinidad) or (Tobago) or (Antigua) or (Barbuda) or (Barbados) or (Martinique) 
or (Dominican Republic) or (Haiti) or (Hispaniola) or (Jamaica) or (Puerto Rico) or (Cuba) or 
(Bahamas) or (Dominica) or (Saint Lucia) or (Grenada) or (Guadeloupe) or (Curacao) or 
(Bonaire) or (Aruba) or (Saba) or (Saint Eustatius) or (Virgin Islands) or (Tortola) or (Virgin 
Gorda) or (Jost Van Dyke) or (Anegada) or (Saint Croix) or (Saint Thomas) or (Saint John) or 
(Saint Kitts) or (Nevis) or (Saint Christopher) or (Sombrero) or (Saint Martin) or (Sint Maarten) 
or (West Indies) or (Saint Vincent) or (Grenadines) or (Eastern Caribbean) or (Greater Antilles) 
or (Lesser Antilles) or (Leeward Islands) or (Windward Islands) or (Caribbean Islands) or 
(Cayman Islands) or (Montserrat) or (Turks and Caicos Islands) or (Anguilla) or (Saint 
Barthelemy)).mp.  
40. 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 
29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 
41. 6 and 14 and 40  
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CINAHL (1961-11th March, 2020) 
1. (MH “type 2 diabetes mellitus”) or (MH “type 2 diabetes”) or (MH “diabetes type 2”) 
2. (MH “diabetes complications”) 
3. MW (“MODY” or ‘NIDDM” or “T2DM”) 
4. MW (typ? 2 or typ? II or typ?2 or typ?II (N diabet$)) 
5. 1 or 2 or 3 or 4 / S1 
6. TX (barrier* or impediment* or challenge* or hindrance* or obstacle* or hurdle* or obstruction* 
or deterrent* or facilitator*) 
7. (MH “qualitative research”) 
8. (MH “interview”) 
9. (MH “focus group”) 
10. (MH “cross-sectional studies”) 
11. (MH “surveys and questionnaires”) 
12. TX (qualitative or interview* or focus group* or cross-sectional or cross sectional or survey*) 
13. 6 or 7 or 8 or 9 or 10 or 11 or 12 / S2 
14. TX ((Caribbean) or (Trinidad) or (Tobago) or (Antigua) or (Barbuda) or (Barbados) or 
(Martinique) or (Dominican Republic) or (Haiti) or (Hispaniola) or (Jamaica) or (Puerto Rico) or 
(Cuba) or (Bahamas) or (Dominica) or (Saint Lucia) or (Grenada) or (Guadeloupe) or (Curacao) 
or (Bonaire) or (Aruba) or (Saba) or (Saint Eustatius) or (Virgin Islands) or (Tortola) or (Virgin 
Gorda) or (Jost Van Dyke) or (Anegada) or (Saint Croix) or (Saint Thomas) or (Saint John) or 
(Saint Kitts) or (Nevis) or (Saint Christopher) or (Sombrero) or (Saint Martin) or (Sint Maarten) 
or (West Indies) or (Saint Vincent) or (Grenadines) or (Eastern Caribbean) or (Greater Antilles) 
or (Lesser Antilles) or (Leeward Islands) or (Windward Islands) or (Caribbean Islands) or 
(Cayman Islands) or (Montserrat) or (Turks and Caicos Islands) or (Anguilla) or (Saint 
Barthelemy)) 
15. MH ((Caribbean) or (Trinidad) or (Tobago) or (Antigua) or (Barbuda) or (Barbados) or 
(Martinique) or (Dominican Republic) or (Haiti) or (Hispaniola) or (Jamaica) or (Puerto Rico) or 
(Cuba) or (Bahamas) or (Dominica) or (Saint Lucia) or (Grenada) or (Guadeloupe) or (Curacao) 
or (Bonaire) or (Aruba) or (Saba) or (Saint Eustatius) or (Virgin Islands) or (Tortola) or (Virgin 
Gorda) or (Jost Van Dyke) or (Anegada) or (Saint Croix) or (Saint Thomas) or (Saint John) or 
(Saint Kitts) or (Nevis) or (Saint Christopher) or (Sombrero) or (Saint Martin) or (Sint Maarten) 
or (West Indies) or (Saint Vincent) or (Grenadines) or (Eastern Caribbean) or (Greater Antilles) 
or (Lesser Antilles) or (Leeward Islands) or (Windward Islands) or (Caribbean Islands) or 
(Cayman Islands) or (Montserrat) or (Turks and Caicos Islands) or (Anguilla) or (Saint 
Barthelemy)) 
16. 14 or 15 / S3 
17. 5 and 13 and 16 / S1 and S2 and S3  
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PsycINFO (1806- 11th March, 2020) 
1. Type 2 diabetes.mp. or Type 2 Diabetes/ 
2. exp Type 2 Diabetes/ or diabetes mellitus, type 2.mp. 
3. (MODY or NIDDM or T2DM).tw,ot. 
4. exp Type 2 Diabetes/ or diabetes complications.mp. 
5.  ((typ? 2 or typ? II or typ?2 or typ?II) adj diabet*).tw,ot. 
6. 1 or 2 or 3 or 4 or 5 
7. (barrier* or impediment* or challenge* or hindrance* or obstacle* or hurdle* or 
obstruction* or deterrent* or facilitator*).mp.  
8. exp qualitative research/  
9. exp interview/  
10. exp Group Discussion/ 
11. exp Group Discussion/ or exp qualitative research/ or focus groups.mp.  
12. cross-sectional studies.mp.  
13. exp surveys/ and questionnaires/  
14. (qualitative or interview* or focus group* or cross-sectional or cross sectional or 
survey*).mp.  
15. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 
16. Caribbean Region.mp. 
17. (Trinidad and Tobago).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
18. (Antigua and Barbuda).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
19. Barbados.mp. 
20. Exp Countries/ or Martinique.mp. 
21. Dominican Republic.mp. 
22. Haiti.mp. 
23. exp Countries/ or Jamaica.mp. 
24. exp Countries/ or Puerto Rico.mp. 
25. exp Countries/ or Cuba.mp. 
26. Bahamas.mp. 
27. Dominica.mp. 





33. Netherlands Antilles.mp. 
34. United States Virgin Islands.mp. 
35. British Virgin Islands.mp. 
 133 
36. (Saint Kitts and Nevis).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
37. Sint Maarten.mp. 
38. West Indies.mp. 
39. (Saint Vincent and the Grenadines).mp. [mp=title, abstract, heading word, table 
of contents, key concepts, original title, tests & measures] 
40. ((Caribbean) or (Trinidad) or (Tobago) or (Antigua) or (Barbuda) or (Barbados) or (Martinique) 
or (Dominican Republic) or (Haiti) or (Hispaniola) or (Jamaica) or (Puerto Rico) or (Cuba) or 
(Bahamas) or (Dominica) or (Saint Lucia) or (Grenada) or (Guadeloupe) or (Curacao) or 
(Bonaire) or (Aruba) or (Saba) or (Saint Eustatius) or (Virgin Islands) or (Tortola) or (Virgin 
Gorda) or (Jost Van Dyke) or (Anegada) or (Saint Croix) or (Saint Thomas) or (Saint John) or 
(Saint Kitts) or (Nevis) or (Saint Christopher) or (Sombrero) or (Saint Martin) or (Sint Maarten) 
or (West Indies) or (Saint Vincent) or (Grenadines) or (Eastern Caribbean) or (Greater Antilles) 
or (Lesser Antilles) or (Leeward Islands) or (Windward Islands) or (Caribbean Islands) or 
(Cayman Islands) or (Montserrat) or (Turks and Caicos Islands) or (Anguilla) or (Saint 
Barthelemy)).mp.  
41. 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 
30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38or 39 or 40 
42. 6 and 15 and 41  
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AMED (1985- 11th March, 2020) 
1. exp diabetes mellitus, type 2/ 
2. exp diabetes complications/ 
3. (“MODY” or “NIDDM” or “T2DM”).af. 
4. ((typ? 2 or typ? II or typ?2 or typ?II) adj diabet*).mp. 
5. 1 or 2 or 3 or 4 
6. (barrier* or impediment* or challenge* or hindrance* or obstacle* or hurdle* or 
obstruction* or deterrent* or facilitator*).mp.  
7. Research/ or qualitative research.mp.  
8. exp interview/  
9. focus groups.mp. 
10. cross-sectional studies.mp. 
11. (surveys and questionnaires).mp. [mp=abstract, heading words, title]  
12. (qualitative or interview* or focus group* or cross-sectional or cross sectional or 
survey*).af.  
13. 6 or 7 or 8 or 9 or 10 or 11 or 12 
14. Caribbean Region.mp. 
15. (Trinidad and Tobago).mp. [mp=abstract, heading words, title] 
16. (Antigua and Barbuda).mp. [mp=abstract, heading words, title] 
17. Barbados.mp. 
18. Martinique.mp. 
19. Dominican Republic.mp. 
20. Haiti.mp. 
21. Jamaica.mp. 
22. Puerto Rico.mp. 
23. Cuba/ or Cuba.mp. 
24. Bahamas.mp. 
25. Dominica.mp. 





31. Netherlands Antilles.mp. 
32. United States Virgin Islands.mp. 
33. British Virgin Islands.mp. 
34. (Saint Kitts and Nevis).mp. [mp=abstract, heading words, title] 
35. Sint Maarten.mp. 
36. West Indies.mp.  
37. (Saint Vincent and the Grenadines).mp. [mp=abstract, heading words, title] 
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38. ((Caribbean) or (Trinidad) or (Tobago) or (Antigua) or (Barbuda) or (Barbados) or (Martinique) 
or (Dominican Republic) or (Haiti) or (Hispaniola) or (Jamaica) or (Puerto Rico) or (Cuba) or 
(Bahamas) or (Dominica) or (Saint Lucia) or (Grenada) or (Guadeloupe) or (Curacao) or 
(Bonaire) or (Aruba) or (Saba) or (Saint Eustatius) or (Virgin Islands) or (Tortola) or (Virgin 
Gorda) or (Jost Van Dyke) or (Anegada) or (Saint Croix) or (Saint Thomas) or (Saint John) or 
(Saint Kitts) or (Nevis) or (Saint Christopher) or (Sombrero) or (Saint Martin) or (Sint Maarten) 
or (West Indies) or (Saint Vincent) or (Grenadines) or (Eastern Caribbean) or (Greater Antilles) 
or (Lesser Antilles) or (Leeward Islands) or (Windward Islands) or (Caribbean Islands) or 
(Cayman Islands) or (Montserrat) or (Turks and Caicos Islands) or (Anguilla) or (Saint 
Barthelemy)).mp.  
39. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 
28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 
40. 5 and 13 and 39 
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Web of Science (1900- 11th March, 2020)  
1.TS=(typ? 2 NEAR/1 diabet? Or diabetes complications or type 2 diabetes mellitus) 
2.TS=(barrier* or impediment* or challenge* or hindrance* or obstacle* or hurdle* or obstruction* or 
deterrent* or facilitator*) 
3. TS=(qualitative or interview* or focus group* or cross-sectional or cross sectional or survey*) 
4. #2 or #3 
5. TS=(Caribbean count* or Caribbean region or Caribbean islands or Caribbean*) 
6. 1 AND 4 AND 5  
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Scopus (1960-111th March, 2020) 
TITLE-ABS-KEY (typ? 2 W/1 diabet? Or diabetes complications or type 2 diabetes mellitus) and (TITLE-
ABS-KEY (barrier* or impediment* or challenge* or hindrance* or obstacle* or hurdle* or obstruction* 
or deterrent* or facilitator*) or TITLE-ABS-KEY (qualitative or interview* or focus group* or cross-
sectional or cross sectional or survey*)) and TITLE-ABS-KEY (Caribbean count* or Caribbean region 
or Caribbean islands or Caribbean*)  
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Unpublished studies 
EthOS- 11th March, 2020 
1. Diabetes 
2. Type 2 diabetes 
3. Caribbean   
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OpenGrey- 11th March, 2020 
type 2 diabetes in the Caribbean  
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ProQuest Dissertations and Theses- 11th March, 2020 
SU((typ? 2 W/1 diabet? Or diabetes complications or type 2 diabetes mellitus)) and SU((barrier* or 
impediment* or challenge* or hindrance* or obstacle* or hurdle* or obstruction* or deterrent* or 
facilitator*)) or SU((qualitative or interview* or focus group* or cross-sectional or cross sectional or 
survey*)) and SU((Caribbean count* or Caribbean region or Caribbean islands or Caribbean*)) 
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Appendix IV: Systematic review study findings and illustrations 
Physical activity in Puerto Rican adults with type 2 diabetes mellitus. Davila(121) 
Finding 1 Positive Benefits to Health Status (U) 
illustration “Improves my diabetes condition and blood circulation.”  
Finding 2 Optimal physical status (U) 
illustration “Physically my body hurts less, I feel lighter and stronger.”  
Finding 3 Optimal psychological status U) 
illustration “I feel good and it cheers me up. My self-esteem increases.” 
Finding 4 Optimal social benefits (U) 
Illustration “When I exercised outside my house I met new friends and I joined a jogging club.” 
Finding 5 Benefits in daily life activities (U) 
Illustration “I am less tired in my other activities.” 
Finding 6 Physical impairments by medical history (U) 
Illustration “When my back condition or knee does not allow me to do it.”  
Finding 7  Overwhelmed by multiple responsibilities from work and home (U) 
Illustration “My work demands many times do not allow me to get home early.” 
Finding 8 Concerns regarding their own safety (U) 
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Illustration “Safety in the area. My husband works and cannot go with me.”   
Finding 9  Motivation and self-esteem (U) 
Illustration “Lack of motivation and interest.” 
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Contextualising Experiences of Diabetes-Related Stress in Rural Dominican Republic. Gonzalez 
Rodriguez et al.(125) 
Finding 1 Sources of stress- Food access and availability (U) 
Illustration  ‘‘There are people who can follow their diet, but many cannot. We often must eat things 
that we should not eat because [living with] hunger is hard. . . . [Diabetes] is harder for 
the poor . . . I would say it is much harder. I feel bad for those of 
us that suffer from this illness. Sometimes I go to sleep hungry, and more so when one 
lives in the countryside. Things in the countryside are very difficult.’’ 
Finding 2 Sources of stress-Medication stress (U).  
Illustration “If you have AIDS, HIV, you have treatment. [handclap] Done. If you are in treatment, 
you can live 100 years and die of something else—you will not die of that [HIV]. But with 
diabetes, a person without treatment can be sure that one day, he will lose his vision. 
Through diabetes comes the famous diabetic foot or kidney problems. It is a tragedy for 
them and their family because now you have lost everything.” 
Finding 3 Sources of stress - Stress-induced stress. (C) 
Illustration ‘‘[Living with diabetes] is worse . . . when you think about it. It is worse because you can 
even die of depression if you think about that, and [it can affect] your heart and all that. 
Finding 4 Coping with stress- Diabetes program Diabetes education and self-management 
techniques provided by cooperadores 
and providers at the clinic alleviated participants’ stress by reducing their uncertainty 
about diabetes. (U) 
Illustration  “Through them, many people have been able to, as they say, [have] a little joy in their 
life because they have totally controlled [their] diabetes . . . it is like a blessing from God 




Living with Diabetes: Experiences from Jamaican Diabetes Clinics in Kingston and Morant Bay. 
Morrissey-Ross et al.(123) 
Finding 1 Doctor appointments (U) 
Illustration  Nathan also expressed the importance of seeing the doctor, saying, “Yes, 
sometimes, I miss my appointment, but I hardly miss my appointment. And in me, 
sometimes if I do, it eating on me…When I miss my appointment…I call and they 
get me in.”  
Finding 2 Obtaining and taking medications (C) 
Illustration Robert, an 82 year old man living in a rural community had suffered with type 2 
DM for 32 years. He attributed his success in managing his disease without the 
onset of kidney disease, heart disease or stroke to taking his medication and regular 
exercise. 
Finding 3 Knowledge of Type 2 Diabetes (U) 
Illustration The motivation that came after increased knowledge was exemplified by Ophelia 
who said, “So me gets-- me finds out now. So me have diabetes. And from thence 
on, me started the change. Them give me a diet sheet. And them tell me what to 
eat, and what not to eat, and so-and-so forth. But you know sometime you may eat 
what you are not supposed to eat.” 
Finding 4 Concerns, worries, and fears (U) 
Illustration  “My concern about having diabetes is when you read up on it, you'll realise that if 
you don't take care of yourself, you can lose a limb and you can even go blind.” 
Finding 5 Most difficult part of having Typ2 2 DM (U) 
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Illustration “It’s not an easy thing. Having diabetes contributes to other sickness and it’s not 
nice, because it become like a part of you gone.” 
Finding 6 Psychosocial support (U) 
Illustration For the majority, supports were multifaceted, ranging from encouraging phone 
calls from concerned sisters overseas to such things as young grandchildren 
assisting with the administration of insulin and a daughter-in-law who visited every 
day on her way to work to check the blood sugar. Gina said, “In Jamaica, if you 
have family somewhere, you’re rich, you know. 
Finding 7 Physiological impact (U) 
Illustration “Ah, diabetes... Whatever I could do first, I cannot do it again…It burdens my body. 
It’s against the body. Walking — I cannot walk straight…The most difficult part is 
over the body... poor circulation too... It look like it caused that too. …me fall down, 
as me step, me fall down…Yes, the nerves gone right out… It burn me under the 
heel and stick me... It can come anywhere… affecting my foot bottom and my heel. 
It burning me, burning me, burning like pepper...and the eyes, man, I don’t know if 
it’s a glaucoma get in the eye and eat out the eye….I can’t tell you how long I am 
suffering, suffering...”  
Finding 8 Relationship with God (U) 
Illustration “Mary, I know that it’s God keeping me. Because there is nothing I don’t talk to Him 
about. I talk to …and tell him Lord, I leave everything to you. So sometimes I feel 
like is Him keeping me. It’s not really like the medication, I think He’s holding me.” 
Finding 9 Partnership with God (U) 
Illustration “You pray a lot about your condition. A way to get comfort.” 
Finding 10 Optimism from faith in God (U) 
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Illustration “He’s keeping me. Me just believe that the diabetes, what I have, the Lord can cut 
it down. I can get healing for it.” 
Finding 11 Economic Impact (U) 
Illustration “You cannot keep a strict diet without money because that come with money. So I 
have to find the money to buy it, and sometimes the drugs are expensive — as for 
the insulin. So if drug store don’t have don’t have insulin, you have to buy the insulin 
because I have to keep on the medication. You’re looking at three thousand or to 
three five (about $24-$28 U.S.) for one vial of insulin.”  
Finding 12 Beliefs about what would help (U) 
Illustration “…the medications are very expensive. No matter how small it is, whatever, I have 
to make sure I put that money aside to fill my prescription. I don't put nothing before 
it.”  
 
Illustration “…what I learn about cerasee tea is that diabetic cannot feel any. It will hide the 
blood sugar… you will do the test, and it show normal with it creeping up.” Iris 
mused, “I tell myself, you see if the bushes worked nobody would have diabetes. 
So if you find yourself with medical problem, go to medical care. I don't believe in 
staying home and doing it yourself.” 
Finding 13 Motivation to seek care (U) 
Illustration “And feeling healthy, that is the best. My mother, when she was alive, she used to 
take care of us, and she take care of herself until she leave us. So that's why I said 
I would take good care of myself just like my mom, and also she take care of her 
mother.” 
Finding 14 Action taken to mitigate the effects of Type 2 DM (U) 
Illustration “My doctor told me what to eat, so I just stick by that. It's not hard as I cut down on 
portion size. Good eating habit, I can tell you. And why I know as I talk about the 
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medication, I was following people and see, you can't get up every day just taking 
tablet, taking tablet.”  
Finding 15 Differences between Genders relative to Type 2 DM (U) 
Illustration “them don’t go for check-ups because them afraid from the doctor." 
  
 148 
Rural Vincentians’ (Caribbean) beliefs about the usage of non-prescribable medicines for treating 
Type 2 diabetes. Moss et al.(122) 
Finding 1 An irregular pattern of usage emerged as plant and prescribed medications were used 
concurrently and interchangeably (U) 
Illustration  “The Doctor medicine is useful … I take it today, tomorrow I take the bush.” 
Finding 2 A contrast in beliefs regarding the efficacy of prescribed medicine for diabetes and the 
nature of the relationship with medical personnel (C) 
Illustration “Doctor say is better for me not to take any tablets. Ah say, “Yes Doctor! Give me the 
tablets.” … You must have yuh tablets to show that you coming to Doctor.” 
Finding 3 Traditional foods as medicine (alternative medicine) (U) 
Illustration “… If you buy ah egg and you bust it a little and you throw it out in the pan, you know 
and you beat it with some of the milk and drink it … that is a medicine!” 
Finding 4 The importance of bitterness in diabetes treatment also emerged from the findings and 
this was perceived as being good  (U) 
Illustration “I could tell you when my sugar raise then. It does pain me head plenty and when ah 
see me head start to pain me ah does say “well is the sugar raise” and when ah go 
and get ah cucumber and ah use that cucumber dey! Betime evening ah feel much 
better. The ache the headache gone then. That feel like the sugar gone down.” 
Finding 5 God was seen to be the source of information on diabetes treatment (U) 
Illustration  “If you say you prayers and you go to yuh bedside and you pray you does get yuh own 
little thing. Sometimes one leaf of bush they will tell you to boil and you know! You feel 
much better.’” 
Finding 6 A lack of belief in the efficacy of prescribable medicines (C) 
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Illustration  Participant C did state that prescribed medicines put her blood glucose up, which she 
rectified by taking both cucumber and carila. 
Finding 7 
 
Use and belief of non-prescribable medicines (U) 
Illustration Herbal medicines were categorised according to their perceived efficacy. Corila was 
described as ‘the strongest one of all’, Shaddom Vinni as a ‘very good thing for the sugar’ 
and Elder Bush as ‘good’ and ‘very good’ 
Finding 8 Control of diabetes was ascribed to a balanced intake of starchy and bitter foods and 
different food types were utilised to give this balance (U) 
Illustration “… If I feel drowsy, sick and I take some food and throw it in me mouth, it carry the 
feelings down. But if you sugar some tea and drink it, throw you down clean, you see.” 
Finding 9 Participants felt that their folk medicine had got the better of conventional medicine (C) 
Illustration This became evident in the face of their amusement that ‘doctor nah know yet’ when he 
was pleased with the improvement in their blood glucose levels that they attributed to 
their herbal medicines. 
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Self-management among Patients Living with Diabetes in the United States Virgin Islands. Nunez et 
al.(112) 
Finding 1 Cultural nuances shaped perspectives on self-management: Use of herbal, 
complementary, and alternative remedies (CAMP) (U) 
Illustration  “(My neighbor) is a diabetic too…. Sometimes she buys bush and give me some. I don’t 
know the name of it but it is supposed to help with sugar. So I use that.” 
Finding 2 Cultural nuances shaped perspectives on self-management: Importance of maintaining 
local diet. (U) 
Illustration “I take liberty every day. Right now I have … 3 plantains, 5 or 6 tanya, sweet potatoes, 
and I plan to take pig tail and cornmeal dumplings and make a big pot of peas soup…. 
You know the attitude I take. I live 70 years eating the same thing. What, now it’s going 
to kill me?” 
Finding 3 Culturally-specific challenges were barriers to effective self-management: Stigma (U) 
Illustration “I think this needs to be more out in the open. Because you can have diabetes and 
control it and do everything that everybody else does. But it’s so secretive … everyone 
will treat you like you’re dying. There’s a stigma attached, yes. To being diabetic or 
having to take medicine for it.” 
Finding 4 Culturally-specific challenges were barriers to effective self-management: Limited 
access to healthy food options/ exercise (U) 
Illustration  “Making the good food choices is hard. They’re simply not available in stores. Well, 
sometimes. Now, they tell me blueberries is good. I can eat that. But when you find that, 
it’s five dollars for a little bag so…” 
Finding 5 Medical homes were rarely viewed as a primary source of diabetes education or support: 
Lack of educational resources (U) 
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Illustration  “I think there should be better resources for diabetics. Once you’re diagnosed there 
should be a place that you can go to for regular classes and monitoring. I can’t believe 
we don’t have that in this day and age. There isn’t even a dietician there (doctor’s office).” 
Finding 6 Medical homes were rarely viewed as a primary source of diabetes education or support: 
Self-adjustment of medication dosing and regimen influenced by friends and family (U) 
Illustration “Well, the doctor told me to take the insulin two times but my mother tell me I want to 
know if this is right. He tell me to take twenty five units in the morning and twenty five in 
the night. But she said it’s too much, and just gives me fifteen at night. So that’s what I 
do.” 
Finding 7 Fear of disease complications largely motivated or stalled self-management practices: 
Denial/Minimisation (U) 
Illustration “I don’t want to think about it (having diabetes). Like I say, I don’t say I’m a diabetic. I 
only say my sugar is a little elevated. I don’t even want to call the word.” 
Finding 8 Fear of disease complications largely motivated or stalled self-management practices: 
Resilience (U) 
Illustration “I see the struggle when people lose limbs. I play the flute and don’t want to lose fingers 
so I changed  everything … I stopped the alcohol. And I cut back on all the starchy, 
Caribbean foods. You have to make up your mind that you’re going to back out of all 
those foods you grew up with. I grow my own vegetables now. And that is another way 
I can get exercise.” 
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Coping with diabetes stress among adults in rural Dominican Republic: “I don’t think about it” 
Sadeghzadeh et al.(126) 
Finding 1 Why people don’t think about diabetes – Almost all participants considered diabetes a 
manageable lifelong condition, such that in achieving diabetic control, they did not have 
to exhaust mental energy to think about diabetes every day. (U) 
Illustration  “I think that with diabetes, you can die from something else that isn’t diabetes. If you 
take your medicine and the necessary care, you aren’t necessarily going to die 
from diabetes.” 
Finding 2 How to not think about diabetes- Reflecting the integration of not thinking about it as 
part of diabetes management (U). 
Illustration I would say to learn how to manage what you eat. Learn how to manage the situation of 
sugar [diabetes]. And don’t think about it. Always have your mind busy with work, and 
exercise. Diabetics shouldn’t just sit. 
Finding 3  How to not think about diabetes - Staying physically and socially active to keep your 
mind busy entailed doing house- hold chores, working (paid employment), volunteering, 
or visiting friends and family (U). 
Illustration “If you are working, your mind will be busy and you won’t remember that you’re sick. 
You’ll live your normal life.” 
Finding 4 How to not think about diabetes - the central role of faith in most rural Dominican 
communities, religion and religious-related practices, such as attending church events 
and reading religious text, kept participants socially engaged and helped them not think 
about 
diabetes. (C) 
Illustration  “I always live with a clear mind because I like to read the word of God.”  
Finding 5  Outcomes of no le doy mente - maintaining a sense of normalcy and protecting their 
health.(U) 
Illustration “. . .living your normal life. Taking your medication, managing your diet. . .doing the 
things that the doctor tells you to do. Sure, all of that. But not thinking, “Oh I am diabetic, 
I am diabetic,” because if I sit here thinking that I am diabetic all day, I will be stuck 
here.” 
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Finding 6 Outcomes of no le doy mente - The influence of seeing others living normal lives is 
notable here, as it reflects the social influence processes of observing others as they 
successfully manage diabetes and live a normal life. (U) 
Illustration “I know there are people who live many years with diabetes, and they have a normal 




Types and Sources of Social Support among Adults Living with Type 2 Diabetes in Rural 
Communities in the Dominican Republic. Wallace et al.(124) 
Finding 1 The path of direct support for diagnosis from friends and neighbours (U) 
Illustration “…She told me, ‘you’re sick, your clothes are loose and falling off of you.’ I agreed. I 
had a t-shirt that I no longer fit in. Dry, I was getting drier, [...to the point that] a man 
told others ‘be fearful of that man, he could have AIDS.’ And I heard that, you see? I 
went to my partner and told her that I felt ill. After that a neighbour took me to the see 
a good doctor to see about my condition where the doctor then tells me, ‘sir, you are 
a diabetic.” 
 
Finding 2 Informational and instrumental support from friends and neighbours to get to the clinic 
(U)  
Illustration “How did I first get here? The man sitting in the waiting room brought me. He found 
out about this program and invited a group of us to go with him. Every month a few of 
us go in his bus for our appointments.” 
Finding 3 Cooperadores played a key role in disseminating diabetes-related information and 
increasing awareness of the diabetes programme in their communities. (U) 
Illustration  “I started here because I used to get checked out in a distant part of the province. 
Then, I went to a public clinic and heard about a diabetes centre from the staff. That 
is how I learned about the programme and that’s how I came here.” 
Finding 4 Cohabitating partners were often the primary supporters mentioned by participants 
when asked ‘who supports you with your diabetes?’ (U) 
Illustration  “Yes, my wife supports me with my treatment. She’ll gives me what I can or should 
eat [for my diet]. If I can’t eat something she does not prepare it.” 
Finding 5 Women had the primary responsibilities of the home such as domestic work and 
preparing family meals, even when those meals were not part of their recommended 
diet. Maintaining the same level of responsibilities they had before having diabetes 
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coupled with reporting little support in the home led to narratives depicting stress and 
frustration. Below Rosa, a 52 year-old female living with diabetes for three years, 
described having limited support at home and how it affected her physically. (U) 
Illustration “No one supports me, no one. How do I say this, even if I feel bad no one pays 
attention. Not even my sisters come to visit and lend me a hand. But God gives me 
strength, because no one else helps me. What happens is that when my sugar levels 
go up, I cannot sleep well and sometimes I get scared. Sometimes my family does 
things I don’t like, which makes me feel ill, like I have high blood pressure. I don’t 
know. Listen, those who have diabetes have to be careful and so they need someone 
who will support them so that they feel better.” 
Finding 6 The role of support from cooperadores, who are tasked with not only supporting 
diabetes care and medication, but also delivering health talks on the importance of 
diabetes self-management strategies to all participants and the community at 
large. These health talks were often referenced in the interviews as a form of 
informational support to learn how best to manage their condition. Cooperdores also 
provided emotional support by showing that they cared about their participants 
through actively listening to their successes and challenges. (U) 
Illustration “Before I came here I felt that everything was crashing around me. Some of us feel 
like we’re drowning in a cup of water because we do not find someone to talk to about 
our problems. But now I can talk to the cooperadores…to the doctor, and I feel better.” 
Finding 7 Physicians served as sounding boards for issues related to their diabetes and their 
day-to-day stressors. (U) 
Illustration “For men, we can suffer from a problem with (sexual) relations. I spoke with the doctor 
when I had a problem [erectile dysfunction]. He told me what I need to do to control 
my sugar otherwise I won’t get better.” 
Finding 8 Support from friends and neighbours was less salient in the long-term management 
stage than the support from partners and providers. (C) 
 156 
Illustration The long-term management stage was characterised by instrumental and emotional 
support from family, especially partners. Healthcare providers and cooperadores 
provided informational and instrumental support to help participants manage their 
diabetes. Friends and neighbours were less salient in this stage compared to the 
diagnosis and programme enrolment stages. Although participants reported a greater 
variety of social support sources in this stage, participants also described the negative 
effects of limited or no support to manage their diabetes. 
Finding 9 Having a friend who ensured that he adhered to his diet was appreciated and helped 
him adhere to his self-management regimen. (U) 
Illustration Miguel: I have a good friend that when we go out to eat, he argues with me about 
what I can eat. He tells me, ‘no you can’t eat this and that, because it’s harmful.’ 
Interviewer: And when he says that, how does that make you feel? Miguel: Good, 
because he’s looking out for me. 
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Knowledge, Motivation and Barriers to Diabetes Control in Adults in Jamaica. Wint et al.(113) 
Finding 1  To keep healthy (N) 
Finding 2 Perceived risk of complications (N) 
Finding 3 Fear of death, discomfort (N) 
Finding 4 Desire to live (N) 
Finding 5 Follow doctors’ orders (N) 
Finding 6 Feeling compelled (N) 
Finding 7 Support from family and friends (N) 
Finding 8 Experience of complications (N) 
Finding 9 Lack of self-monitoring of blood glucose (N) 
Finding 10 Lack of perceived risk of complications (N) 
Finding 11 Overweight or obese state (N) 
Finding 12 Inadequate knowledge (N) 
Finding 13 Little motivation to maintain health (N) 
Finding 14 Non-compliance with medication (N) 
Finding 15 Little effort to control diet (N) 
Finding 16 Use of “bush teas” (N) 
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Finding 17 Belief that diabetes can be cures (N) 
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Appendix V: Systematic review studies ineligible for full text review 
Studies excluded on full-text examination 
References Reasons for exclusion  
Apparico N, Clerk N, Henry G, Seale J, Sealy R, Ward S, et al. How well controlled are our type 2 diabetic patients in 
2002?. An observational study in North and Central Trinidad. Diabetes Res Clin Pract [Internet]. 2007;75(3):301–5. 
Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed10&NEWS=N&AN=46091812 
Quantitative studies / cross-
sectional surveys that contain no 
free text  
Foster T, Mowatt L, Mullings J. Knowledge, beliefs and practices of patients with diabetic retinopathy at the University 
Hospital of the West Indies, Jamaica. J Community Health [Internet]. 2016;41(3):584–92. Available from: 
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emexa&NEWS=N&AN=620155270 
Quantitative studies / cross-
sectional surveys that contain no 
free text  
Ezenwaka C, Olukoga A, Onuoha P, Worrell R, Skinner T, Mayers H, et al. Perceptions of Caribbean type 2 diabetes 
patients on self-monitoring of blood glucose. Arch Physiol Biochem [Internet]. 2012;118(1):16–21. Available from: 
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med7&NEWS=N&AN=22103450 
Quantitative studies / cross-
sectional surveys that contain no 
free text  
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